Clinical Trials
Cyclosporine has been evaluated in numerous clinical trials across all development phases, investigating indications such as post-renal transplantation complications, non-melanoma skin cancer in transplant recipients, immunosuppression management, severe aplastic anemia, focal segmental glomerulosclerosis, and moderate-to-severe atopic dermatitis. These studies, sponsored by major pharmaceutical companies like Pfizer and Galderma R&D alongside academic institutions such as Children's Hospital of Philadelphia and Peking Union Medical College Hospital, span recruitment statuses from active and recruiting to completed, terminated, and withdrawn.
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT04877288 | RECRUITING | Renal Allograft Recipients |
Bristol-Myers Squibb |
2021-07-21 | PHASE3 |
| NCT06013423 | RECRUITING | Acute Leukemia of Ambiguous Lineage; Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Blastic Plasmacytoid Dendritic Cell Neoplasm; Hematopoietic and Lymphatic System Neoplasm; Mixed Phenotype Acute Leukemia; Myelodysplastic Syndrome; Myeloproliferative Neoplasm; Non-Hodgkin Lymphoma; Chronic Myeloid Leukemia, BCR-ABL1 Positive |
Fred Hutchinson Cancer Center |
2024-07-23 | PHASE2 |
| NCT05600426 | ACTIVE_NOT_RECRUITING | Severe Aplastic Anemia |
Boston Children's Hospital |
2023-01-25 | PHASE3 |
| NCT07345000 | NOT_YET_RECRUITING | Treatment-naïve Severe Aplastic Anemia |
Qilu Pharmaceutical Co., Ltd. |
2026-01 | PHASE3 |
| NCT07739914 | NOT_YET_RECRUITING | Liver Allograft; Liver Diseases; Liver Transplantation |
Hannover Medical School |
2026-06-30 | PHASE3 |
| NCT01624805 | RECRUITING | Aplastic Anemia; de Novo Myelodysplastic Syndrome; Myelodysplastic Syndrome; Previously Treated Myelodysplastic Syndrome |
M.D. Anderson Cancer Center |
2012-06-25 | PHASE2 |
| NCT07523009 | WITHDRAWN | Severe Aplastic Anemia (SAA); Transfusion-dependent Non-severe Aplastic Anemia |
Peking Union Medical College Hospital |
2026-06 | PHASE2 |
| NCT07558434 | NOT_YET_RECRUITING | Severe Aplastic Anemia (SAA); Transfusion-dependent Non-severe Aplastic Anemia |
Peking Union Medical College Hospital |
2026-04 | PHASE2 |
| NCT07548671 | NOT_YET_RECRUITING | Transfusion-dependent Non-severe Aplastic Anemia |
Peking Union Medical College Hospital |
2026-04 | PHASE3 |
| NCT07653581 | NOT_YET_RECRUITING | Lower-risk Myelodysplastic Syndromes |
Peking Union Medical College Hospital |
2026-06 | PHASE3 |
| NCT04488081 | ACTIVE_NOT_RECRUITING | COVID-19 |
QuantumLeap Healthcare Collaborative |
2020-07-31 | PHASE2 |
| NCT06364319 | NOT_YET_RECRUITING | cGVHD |
Peking University People's Hospital |
2026-07-15 | PHASE4 |
| NCT03970096 | RECRUITING | Acute Leukemia; Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Myelodysplastic Syndrome; Myeloproliferative Neoplasm |
Fred Hutchinson Cancer Center |
2019-11-19 | PHASE2 |
| NCT04888741 | RECRUITING | Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Chronic Myelomonocytic Leukemia; Myelodysplastic Syndromes; Non Hodgkin Lymphoma; Hodgkin Lymphoma; Multiple Myeloma; Chronic Myelogenous Leukemia; Myelofibrosis |
University of Birmingham |
2021-02-22 | PHASE2 |
| NCT03128034 | RECRUITING | Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome; Acute Myeloid Leukemia; Chronic Myelomonocytic Leukemia; Myelodysplastic Syndrome With Excess Blasts; Recurrent Acute Myeloid Leukemia; Refractory Acute Lymphoblastic Leukemia; Recurrent Acute Lymphoblastic Leukemia; Recurrent Mixed Phenotype Acute Leukemia; Refractory Acute Myeloid Leukemia; Refractory Mixed Phenotype Acute Leukemia; Mixed Phenotype Acute Leukemia |
Fred Hutchinson Cancer Center |
2017-10-24 | PHASE1; PHASE2 |
| NCT07366801 | RECRUITING | Acute Myeloid Leukemia, Relapsed; Acute Lymphoblastic Leukemia, High Risk; Acute Myeloid Leukemia, High Risk; Acute Lymphoblastic Leukemia, Relapse |
Federal Research Institute of Pediatric Hematology, Oncology and Immunology |
2025-09-03 | PHASE2; PHASE3 |
| NCT07368595 | NOT_YET_RECRUITING | Dry Eye Disease (DED) |
Baylor College of Medicine |
2026-09-01 | PHASE4 |
| NCT06642909 | ACTIVE_NOT_RECRUITING | Primary Membranous Nephropathy |
BioRay Pharmaceutical Co., Ltd. |
2024-11-13 | PHASE2 |
| NCT06790095 | ENROLLING_BY_INVITATION | Traumatic Brain Injury |
University of California, San Francisco |
2026-07-02 | PHASE2 |
| NCT04375631 | RECRUITING | Recurrent Acute Myeloid Leukemia; Recurrent Chronic Myelomonocytic Leukemia; Recurrent Myelodysplastic Syndrome; Refractory Acute Myeloid Leukemia; Refractory Chronic Myelomonocytic Leukemia; Refractory Mixed Phenotype Acute Leukemia; Refractory Myelodysplastic Syndrome; Refractory Acute Leukemia of Ambiguous Lineage; Refractory Acute Undifferentiated Leukemia |
Fred Hutchinson Cancer Center |
2020-12-03 | PHASE1 |
| NCT07224529 | RECRUITING | Meibomian Gland Dysfunction (MGD) |
University of Alabama at Birmingham |
2026-06-01 | PHASE4 |
| NCT05946772 | RECRUITING | Takotsubo Cardiomyopathy |
University Hospital Heidelberg |
2025-02-01 | PHASE2 |
| NCT06470191 | RECRUITING | Primary Membranous Nephropathy |
Shanghai Jiaolian Drug Research and Development Co., Ltd |
2024-07-30 | PHASE2; PHASE3 |
| NCT04644016 | RECRUITING | AML; ALL; MDS; MPD Withou Myelofibrosis; NHL or HL; Inherited Metabolic Disorders; Hemoglobinopathies; Bone Marrow Failure; HLH |
Memorial Sloan Kettering Cancer Center |
2020-11-20 | PHASE2 |
| NCT07565441 | NOT_YET_RECRUITING | ADPKD (Autosomal Dominant Polycystic Kidney Disease) |
Jemincare |
2026-05-11 | PHASE1 |
| NCT05057468 | RECRUITING | Primary Autoimmune Hemolytic Anemia |
Assiut University |
2021-10-20 | PHASE3 |
| NCT07029204 | ACTIVE_NOT_RECRUITING | Alopecia Areata |
University of California, Davis |
2025-08-19 | EARLY_PHASE1 |
| NCT04988256 | ENROLLING_BY_INVITATION | DRESS Syndrome; Drug-Induced Hypersensitivity Syndrome |
University of Southern California |
2021-09-27 | EARLY_PHASE1 |
| NCT05936086 | RECRUITING | Hemophagocytic Syndrome |
shifeng Lou |
2023-04-20 | |
| NCT04039347 | TERMINATED | Bronchiolitis Obliterans; Obliterative Bronchiolitis; Bronchiolitis Obliterans Syndrome |
Zambon SpA |
2020-03-12 | PHASE3 |
| NCT06766357 | RECRUITING | Moderate to Severe Dry Eye |
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. |
2025-04-03 | PHASE3 |
| NCT06752694 | ACTIVE_NOT_RECRUITING | Aplastic Anemia |
Fred Hutchinson Cancer Center |
2025-09-25 | PHASE2 |
| NCT06348602 | UNKNOWN | Ocular Graft-versus-host Disease |
Hospital Universitario Dr. Jose E. Gonzalez |
2023-08-01 | PHASE1; PHASE2 |
| NCT05112263 | UNKNOWN | Ulcerative Colitis |
Post Graduate Institute of Medical Education and Research, Chandigarh |
2023-07-01 | |
| NCT07375654 | COMPLETED | Psoriasis |
Cairo University |
2024-12-19 | PHASE1 |
| NCT06392438 | UNKNOWN | Dry Eye; Contact Lens Complication |
Université de Sherbrooke |
2024-04-25 | PHASE3 |
| NCT02416388 | RECRUITING | Acute Myeloid Leukemia (AML) |
University Hospital, Angers |
2015-01 | PHASE2; PHASE3 |
| NCT06329661 | COMPLETED | Dry Eye Disease; Endothelial Cell |
Novaliq GmbH |
2024-04-22 | PHASE4 |
| NCT06525948 | UNKNOWN | Aplastic Anemia; Transfusion-dependent Anemia |
Peking Union Medical College Hospital |
2024-07-30 | PHASE4 |
| NCT06809608 | COMPLETED | Healthy Participants |
Hoffmann-La Roche |
2025-02-13 | PHASE1 |
| NCT06837259 | COMPLETED | Healthy Adults |
Pfizer |
2025-03-19 | PHASE1 |
| NCT07239128 | COMPLETED | Dry Eye Disease (DED) |
University of Seville |
2024-05-01 | EARLY_PHASE1 |
| NCT03456817 | TERMINATED | Graft-versus-host-disease; Relapse |
AHS Cancer Control Alberta |
2020-07-01 | PHASE2 |
| NCT03246906 | TERMINATED | Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Aggressive Non-Hodgkin Lymphoma; Chronic Lymphocytic Leukemia; Diffuse Large B-Cell Lymphoma; Mantle Cell Lymphoma; Myelodysplastic Syndrome; Myelodysplastic/Myeloproliferative Neoplasm; Prolymphocytic Leukemia; Recurrent Chronic Lymphocytic Leukemia; Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Recurrent Hodgkin Lymphoma; Recurrent Plasma Cell Myeloma; Recurrent Small Lymphocytic Lymphoma; Recurrent Waldenstrom Macroglobulinemia; Hematologic and Lymphocytic Disorder; Blastic Plasmacytoid Dendritic Cell Neoplasm |
Fred Hutchinson Cancer Center |
2017-09-11 | PHASE2 |
| NCT06424639 | WITHDRAWN | Aplastic Anemia |
Peking Union Medical College Hospital |
2024-05 | PHASE4 |
| NCT03434730 | COMPLETED | Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Acute Leukemia; Myelodysplastic Syndromes; Myelodysplastic-Myeloproliferative Diseases; Myeloproliferative Disorder; Non Hodgkin Lymphoma; Hodgkin Lymphoma; Leukemia |
Memorial Sloan Kettering Cancer Center |
2018-02-07 | PHASE2 |
| NCT04813653 | COMPLETED | Multiple Myeloma in Relapse; Multiple Myeloma, Refractory |
Tel-Aviv Sourasky Medical Center |
2021-04-18 | PHASE1 |
| NCT05398653 | COMPLETED | Primary Membranous Nephropathy |
Beijing Mabworks Biotech Co., Ltd. |
2022-02-24 | PHASE1; PHASE2 |
| NCT05323617 | WITHDRAWN | Severe Aplastic Anemia (SAA) |
Amgen |
2023-08-31 | PHASE2 |
| NCT05399732 | COMPLETED | Aplastic Anemia |
Bing Han |
2022-12-19 | PHASE2 |
| NCT05660785 | COMPLETED | Non Severe Aplastic Anemia; Untreated |
Institute of Hematology & Blood Diseases Hospital, China |
2022-12-01 | PHASE2 |
| NCT06624384 | NOT_YET_RECRUITING | Ocular Surface Symptom; Ocular Surface Disease; Eye Pain; Eye Inflammation |
Mohsen Pourazizi |
2024-10-30 | PHASE1 |
| NCT04795752 | COMPLETED | Dry Eye; Meibomian Gland Dysfunction |
Sight Sciences, Inc. |
2021-04-28 | |
| NCT04530487 | TERMINATED | Desmoplastic Small Round Cell Tumor; Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor; Recurrent Desmoplastic Small Round Cell Tumor; Recurrent Malignant Peripheral Nerve Sheath Tumor; Recurrent Malignant Solid Neoplasm; Recurrent Neuroblastoma; Recurrent Rhabdomyosarcoma; Refractory Desmoplastic Small Round Cell Tumor; Refractory Malignant Peripheral Nerve Sheath Tumor; Refractory Malignant Solid Neoplasm; Refractory Neuroblastoma; Refractory Rhabdomyosarcoma |
M.D. Anderson Cancer Center |
2020-08-19 | PHASE2 |
| NCT06004752 | UNKNOWN | Aplastic Anemia |
Peking Union Medical College Hospital |
2023-08-17 | PHASE2 |
| NCT06482177 | COMPLETED | Dry Eye |
Research Insight LLC |
2023-10-12 | PHASE4 |
| NCT00357565 | COMPLETED | Leukemia; Myelodysplastic Syndromes; Childhood Acute Myeloid Leukemia in Remission; Recurrent Childhood Acute Myeloid Leukemia; Secondary Acute Myeloid Leukemia; Childhood Acute Lymphoblastic Leukemia in Remission; Previously Treated Myelodysplastic Syndrome; Secondary Myelodysplastic Syndrome; Refractory Anemia With Excess Blasts in Transformation; Refractory Anemia With Excess Blasts; Refractory Anemia; De Novo Myelodysplastic Syndrome; Childhood Myelodysplastic Syndrome |
Masonic Cancer Center, University of Minnesota |
2005-11 | PHASE2 |
| NCT05579769 | TERMINATED | Hematologic Malignancy; Myeloid Malignancy |
St. Jude Children's Research Hospital |
2023-03-14 | PHASE2 |
| NCT03657342 | COMPLETED | Bronchiolitis Obliterans; Chronic Rejection of Lung Transplant; Lung Transplant Rejection; Lung Transplant; Complications; Lung Transplant Failure and Rejection; Chronic Lung Allograft Dysfunction |
Zambon SpA |
2019-03-26 | PHASE3 |
| NCT05702931 | Not yet recruiting | Hyperglycemia|Renal Transplant Complication Primary Non-Function|Diabetes |
Rigshospitalet Denmark|Aarhus University Hospital|Odense University Hospital |
2024-04-01 | Phase 4 |
| NCT03656926 | COMPLETED | Bronchiolitis Obliterans; Chronic Rejection of Lung Transplant; Lung Transplant Rejection; Lung Transplant; Complications; Lung Transplant Failure and Rejection; Chronic Lung Allograft Dysfunction |
Zambon SpA |
2019-03-26 | PHASE3 |
| NCT05957211 | COMPLETED | Dry Eye Disease |
University of Waterloo |
2023-05-19 | |
| NCT05696977 | UNKNOWN | Nephrotic Syndrome |
Alexandria University |
2022-04-17 | PHASE4 |
| NCT06936462 | COMPLETED | Dry Eye Syndrome (DES) |
Hallym University Kangnam Sacred Heart Hospital |
2020-01-20 | |
| NCT04878770 | UNKNOWN | Dermatitis, Atopic |
Erasmus Medical Center |
2021-08-16 | |
| NCT04515329 | WITHDRAWN | Dry Eye |
Vishal Jhanji |
2023-12-08 | PHASE4 |
| NCT05782933 | UNKNOWN | Idiopathic Membranous Nephropathy |
Beijing Friendship Hospital |
2022-08-04 | |
| NCT04622956 | UNKNOWN | Graft Vs Host Disease; Hematopoietic Neoplasm |
University of Sao Paulo General Hospital |
2020-10-07 | PHASE1; PHASE2 |
| NCT06005714 | COMPLETED | The Effects of Clarithromycin or Cyclosporine on Pharmacokinetics of Deuterium Hydrobromide Ramidvir Tablets in Healthy Chinese Subjects |
Shanghai Vinnerna Biosciences Co., Ltd. |
2023-08-15 | PHASE1 |
| NCT02144857 | UNKNOWN | Psoriasis |
University of Athens |
2014-05-30 | PHASE4 |
| NCT05293509 | WITHDRAWN | Stem Cell Transplantation |
M.D. Anderson Cancer Center |
2022-03-02 | PHASE2 |
| NCT03602898 | WITHDRAWN | Acute Lymphoblastic Leukemia in Remission; Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome; Chronic Myelomonocytic Leukemia; Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Hematopoietic and Lymphoid System Neoplasm; Myelodysplastic Syndrome; Myelofibrosis; Myeloproliferative Neoplasm; Recurrent Acute Myeloid Leukemia; Recurrent Hodgkin Lymphoma; Recurrent Non-Hodgkin Lymphoma; Refractory Acute Myeloid Leukemia; Therapy-Related Acute Myeloid Leukemia |
Fred Hutchinson Cancer Center |
2021-06-01 | PHASE2 |
| NCT05955924 | Recruiting | Non-melanoma Skin Cancer|Carcinoma Squamous Cell|Carcinoma Basal Cell|Keratinocyte Carcinoma |
Women''s College Hospital|Canadian Institutes of Health Research (CIHR)|University Health Network Toronto|NOW Foods |
2023-08-28 | Phase 3 |
| NCT04895423 | UNKNOWN | Atopic Dermatitis |
National Medical Research Center for Children's Health, Russian Federation |
2021-11-25 | PHASE4 |
| NCT04989686 | Recruiting | Immunosuppression |
Children''s Hospital of Philadelphia|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
2023-06-08 | -- |
| NCT05136170 | COMPLETED | Dry Eye Disease |
Dompé Farmaceutici S.p.A |
2022-01-27 | PHASE3 |
| NCT04918823 | COMPLETED | Ocular Surface Disease |
Boston Sight |
2021-07-15 | PHASE1; PHASE2 |
| NCT01811368 | UNKNOWN | Refractory Non Hodgkin Lymphoma; Relapsed Non Hodgkin Lymphoma |
Joseph Tuscano |
2013-03-12 | PHASE2 |
| NCT05745701 | Completed | Healthy |
Pfizer |
2023-02-22 | Phase 1 |
| NCT05149313 | COMPLETED | Dermatitis, Atopic; Eczema |
Almirall, S.A. |
2021-12-23 | PHASE3 |
| NCT05573230 | COMPLETED | Healthy |
Eli Lilly and Company |
2022-10-17 | PHASE1 |
| NCT04781803 | UNKNOWN | Stem Cell Transplant Complications; Cytokine Release Syndrome |
Hospital Universitario Dr. Jose E. Gonzalez |
2021-03-25 | PHASE2 |
| NCT05056779 | Withdrawn | Moderate-to-severe Atopic Dermatitis |
Galderma R&D |
2023-01 | Phase 3 |
| NCT04692376 | UNKNOWN | Chronic Graft-versus-host Disease |
Nanfang Hospital, Southern Medical University |
2021-01-10 | PHASE2 |
| NCT04743739 | TERMINATED | Idiopathic Membranous Nephropathy |
Peking Union Medical College Hospital |
2021-04-14 | PHASE3 |
| NCT03413306 | UNKNOWN | Acquired Aplastic Anemia |
Federal Research Institute of Pediatric Hematology, Oncology and Immunology |
2016-12-10 | PHASE3 |
| NCT05245604 | UNKNOWN | Dry Eye Syndrome |
Taejoon Pharmaceutical Co., Ltd. |
2020-06-19 | PHASE3 |
| NCT04470804 | COMPLETED | Pure Red Cell Aplasia, Acquired |
Bing Han |
2020-07-01 | PHASE4 |
| NCT04357795 | COMPLETED | Dry Eye Disease |
Sun Pharmaceutical Industries Limited |
2020-06-29 | PHASE4 |
| NCT05627947 | COMPLETED | Pterygium |
Egymedicalpedia |
2021-01-01 | PHASE1 |
| NCT04328727 | COMPLETED | Severe Aplastic Anemia (SAA) |
Novartis Pharmaceuticals |
2020-11-04 | PHASE2 |
| NCT03013933 | COMPLETED | Recurrent Hodgkin Lymphoma; Refractory Hodgkin Lymphoma |
City of Hope Medical Center |
2017-05-03 | PHASE1 |
| NCT02907554 | COMPLETED | Brain Death; Kidney Transplantation |
University Hospital, Clermont-Ferrand |
2017-12-19 | PHASE4 |
| NCT04734197 | COMPLETED | Dry Eye Disease |
Surface Ophthalmics, Inc. |
2021-01-11 | PHASE2 |
| NCT04555694 | COMPLETED | Dry Eye |
Thomas Chester, OD |
2020-10-01 | PHASE4 |
| NCT04426240 | COMPLETED | Dry Eye Syndromes |
Samsung Medical Center |
2020-08-03 | PHASE4 |
| NCT02498977 | TERMINATED | Transplantation, Liver |
King's College London |
2015-10 | PHASE4 |
| NCT02867800 | COMPLETED | Sickle Cell Disease; Graft Versus Host Disease |
Monica Bhatia |
2016-07 | PHASE1 |
| NCT00796068 | COMPLETED | Acute Biphenotypic Leukemia; Acute Lymphoblastic Leukemia in Remission; Acute Myeloid Leukemia in Remission; Blasts Under 5 Percent of Bone Marrow Nucleated Cells; Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Myelodysplastic Syndrome (MDS) |
Fred Hutchinson Cancer Center |
2009-02-24 | PHASE2 |
| NCT05691764 | COMPLETED | Myocardial Injury; Cardiac Surgery |
Indonesia University |
2020-09-01 | |
| NCT02745717 | COMPLETED | Severe Aplastic Anemia |
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine |
2016-01 | PHASE4 |
| NCT04412785 | COMPLETED | COVID-19 |
University of Pennsylvania |
2020-06-30 | PHASE1 |
| NCT04127851 | COMPLETED | Dry Eye; Dry Eye Syndromes |
Taejoon Pharmaceutical Co., Ltd. |
2019-11-12 | PHASE4 |
| NCT05294666 | COMPLETED | Graft Versus Host Disease in Eye |
Peking University Third Hospital |
2020-04-01 | PHASE4 |
| NCT04849299 | COMPLETED | Healthy Volunteer Study |
Atea Pharmaceuticals, Inc. |
2021-04-18 | PHASE1 |
| NCT04392531 | COMPLETED | COVID19 Infection |
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz |
2020-04-16 | PHASE4 |
| NCT02370550 | UNKNOWN | Sjogren's Syndrome |
Peking University People's Hospital |
2015-03 | PHASE4 |
| NCT03336632 | UNKNOWN | Leukemia, Acute; MDS |
Sichuan University |
2019-01-01 | PHASE2 |
| NCT04542252 | COMPLETED | Drug Drug Interaction |
SymBio Pharmaceuticals |
2020-11-09 | PHASE1 |
| NCT02099747 | COMPLETED | Severe Aplastic Anemia |
European Society for Blood and Marrow Transplantation |
2015-07 | PHASE3 |
| NCT04532918 | COMPLETED | Chronic Kidney Disease |
AstraZeneca |
2020-09-10 | PHASE1 |
| NCT02998645 | COMPLETED | Severe Aplastic Anemia |
Novartis Pharmaceuticals |
2017-05-11 | PHASE2 |
| NCT02462252 | COMPLETED | Aplastic Anemia; Hypoplastic Myelodysplastic Syndrome |
BioLineRx, Ltd. |
2015-10 | PHASE2 |
| NCT04637633 | COMPLETED | Epiphora |
Farwaniya Hospital |
2020-08-15 | PHASE2; PHASE3 |
| NCT04906304 | COMPLETED | Cytomegalovirus Infections |
Shahid Beheshti University of Medical Sciences |
2020-01-01 | |
| NCT04451239 | UNKNOWN | Keratonjunctivitis |
Ameera Gamal Abdelhameed |
2020-06-30 | |
| NCT00741455 | COMPLETED | Hematologic Malignancies |
Dartmouth-Hitchcock Medical Center |
2004-06 | |
| NCT04023760 | COMPLETED | Pharmacokinetics; Kidney Transplant; Lung Transplant |
University of Saskatchewan |
2019-06-26 | PHASE4 |
| NCT02756572 | COMPLETED | Blasts 10 Percent or More of Bone Marrow Nucleated Cells; Chronic Myelomonocytic Leukemia-2; High Grade Malignant Neoplasm; Myelodysplastic Syndrome; Myelodysplastic Syndrome With Excess Blasts-2; Myeloid Neoplasm; Previously Treated Myelodysplastic Syndrome; Recurrent Acute Myeloid Leukemia; Refractory Acute Myeloid Leukemia |
University of Washington |
2016-09-22 | PHASE2 |
| NCT03150134 | UNKNOWN | Acute Myeloid Leukemia; Disorder Related to Bone Marrow Transplantation |
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine |
2010-01-01 | PHASE4 |
| NCT04673604 | COMPLETED | Glaucoma; Ocular Surface Disease |
Aristotle University Of Thessaloniki |
2018-05-06 | |
| NCT02181478 | COMPLETED | Acute Lymphoblastic Leukemia; Acute Myelogenous Leukemia; Myelodysplastic Syndromes; Myelofibrosis; Relapsed Non-Hodgkin Lymphoma; Refractory Non-Hodgkin Lymphoma; Hodgkin Lymphoma; Refractory Hodgkin Lymphoma; Relapsed Chronic Lymphocytic Leukemia; Refractory Chronic Lymphocytic Leukemia; Lymphoid Malignancies; Chronic Myelogenous Leukemia |
Case Comprehensive Cancer Center |
2015-07-22 | EARLY_PHASE1 |
| NCT03428100 | COMPLETED | Atopic Dermatitis |
Eli Lilly and Company |
2018-05-15 | PHASE3 |
| NCT04149678 | COMPLETED | Healthy Volunteers |
Celgene |
2019-10-04 | PHASE1 |
| NCT01820572 | COMPLETED | Kidney Transplantation |
Bristol-Myers Squibb |
2013-03-27 | PHASE3 |
| NCT00309842 | COMPLETED | Acute Myeloid Leukemia; Acute Lymphocytic Leukemia; Chronic Myelogenous Leukemia; Myelofibrosis; MDS; Refractory Anemia; Chronic Lymphocytic Leukemia; Prolymphocytic Leukemia; Non-Hodgkin's Lymphoma; Leukemia; Lymphoma; Multiple Myeloma; Myelodysplastic Syndromes |
Masonic Cancer Center, University of Minnesota |
2005-07-28 | PHASE2 |
| NCT03218657 | UNKNOWN | Aplastic Anemia |
Shengyun Lin |
2018-01-01 | |
| NCT01273207 | COMPLETED | Bronchiolitis Obliterans; Constructive Bronchiolitis; Graft Versus Host Disease; Bronchiolitis, Exudative; Bronchiolitis, Proliferative; Graft-Versus-Host Disease |
National Heart, Lung, and Blood Institute (NHLBI) |
2012-03-02 | PHASE2 |
| NCT00303719 | TERMINATED | Kidney Cancer; Leukemia; Lymphoma; Multiple Myeloma; Plasma Cell Neoplasm; Myelodysplastic Syndromes |
Masonic Cancer Center, University of Minnesota |
2002-03-26 | PHASE2 |
| NCT03768609 | COMPLETED | Healthy |
Janssen-Cilag International NV |
2018-12-06 | PHASE1 |
| NCT02435901 | COMPLETED | Sickle Cell Disease; Beta Thalassemia-Major |
Northwell Health |
2008-12 | PHASE1; PHASE2 |
| NCT03865888 | COMPLETED | Dry Eye; Sjogren Syndrome |
Pavly Moawd |
2018-10-30 | PHASE3 |
| NCT01252667 | COMPLETED | Acute Myeloid Leukemia |
Fred Hutchinson Cancer Center |
2011-01-25 | PHASE2 |
| NCT00047060 | COMPLETED | Mycosis Fungoides; Sezary Syndrome |
National Heart, Lung, and Blood Institute (NHLBI) |
2002-07-30 | PHASE1; PHASE2 |
| NCT02887807 | WITHDRAWN | Shockable Out of Hospital Cardiac Arrest |
Hospices Civils de Lyon |
2017-01 | PHASE3 |
| NCT00003838 | COMPLETED | Myeloproliferative Disorders; Acute Myelogenous Leukemia; Chronic Myelogenous Leukemia; Myelodysplastic Syndrome; Acute Lymphoblastic Leukemia |
National Heart, Lung, and Blood Institute (NHLBI) |
1999-04-15 | PHASE2 |
| NCT01251575 | COMPLETED | Adult Acute Lymphoblastic Leukemia; Adult Acute Myeloid Leukemia; Adult Diffuse Large B-Cell Lymphoma; Adult Myelodysplastic Syndrome; Adult Non-Hodgkin Lymphoma; Aggressive Non-Hodgkin Lymphoma; Childhood Acute Lymphoblastic Leukemia; Childhood Acute Myeloid Leukemia; Childhood Diffuse Large B-Cell Lymphoma; Childhood Myelodysplastic Syndrome; Childhood Non-Hodgkin Lymphoma; Chronic Lymphocytic Leukemia; Chronic Lymphocytic Leukemia in Remission; Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Hematopoietic and Lymphoid Cell Neoplasm; Mantle Cell Lymphoma; Plasma Cell Myeloma; Prolymphocytic Leukemia; Recurrent Chronic Lymphocytic Leukemia; Refractory Chronic Lymphocytic Leukemia; T-Cell Prolymphocytic Leukemia; Waldenstrom Macroglobulinemia; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Hodgkin Lymphoma |
Fred Hutchinson Cancer Center |
2010-12-01 | PHASE2 |
| NCT03750383 | COMPLETED | RSV Infection |
Enanta Pharmaceuticals, Inc |
2018-11-02 | PHASE1 |
| NCT05109390 | COMPLETED | Healthy |
Alexion Pharmaceuticals, Inc. |
2018-07-27 | PHASE1 |
| NCT01527045 | COMPLETED | Aggressive Non-Hodgkin Lymphoma; Blasts Under 5 Percent of Bone Marrow Nucleated Cells; Chronic Lymphocytic Leukemia; Loss of Chromosome 17p; Myelodysplastic/Myeloproliferative Neoplasm; Non-Hodgkin Lymphoma; Prolymphocytic Leukemia; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Aggressive Adult Non-Hodgkin Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Recurrent Chronic Lymphocytic Leukemia; Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Hodgkin Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Non-Hodgkin Lymphoma; Recurrent Plasma Cell Myeloma; Recurrent Small Lymphocytic Lymphoma; Waldenstrom Macroglobulinemia |
Fred Hutchinson Cancer Center |
2012-09-25 | PHASE2 |
| NCT02876250 | WITHDRAWN | Lung Transplantation |
Hospices Civils de Lyon |
2017-01 | PHASE3 |
| NCT01287078 | COMPLETED | Constrictive Bronchiolitis; Bronchiolitis Obliterans; Graft vs Host Disease; Bronchiolitis, Exudative; Bronchiolitis, Proliferative |
National Heart, Lung, and Blood Institute (NHLBI) |
2011-01-29 | PHASE2 |
| NCT00723099 | COMPLETED | Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Aggressive Non-Hodgkin Lymphoma; Chronic Myelogenous Leukemia; Chronic Phase Chronic Myelogenous Leukemia; Indolent Non-Hodgkin Lymphoma; Lymphoma; Mixed Phenotype Acute Leukemia; Myelodysplastic Syndrome; Myeloproliferative Neoplasm; Recurrent Chronic Lymphocytic Leukemia; Recurrent Follicular Lymphoma; Recurrent Lymphoplasmacytic Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Plasma Cell Myeloma; Recurrent Small Lymphocytic Lymphoma; Recurrent T-Cell Non-Hodgkin Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Chronic Myelogenous Leukemia; Refractory Follicular Lymphoma; Refractory Hodgkin Lymphoma; Refractory Lymphoplasmacytic Lymphoma; Refractory Mantle Cell Lymphoma; Refractory Small Lymphocytic Lymphoma; T-Cell Non-Hodgkin Lymphoma |
Fred Hutchinson Cancer Center |
2008-06-25 | PHASE2 |
| NCT01976390 | COMPLETED | Renal Failure |
Ohio State University |
2013-10-01 | |
| NCT03419910 | COMPLETED | Psoriasis |
Bristol-Myers Squibb |
2018-03-05 | PHASE1 |
| NCT00104858 | COMPLETED | Chronic Lymphocytic Leukemia; Prolymphocytic Leukemia; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Stage III Chronic Lymphocytic Leukemia; Stage III Small Lymphocytic Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Small Lymphocytic Lymphoma; T-Cell Large Granular Lymphocyte Leukemia |
Fred Hutchinson Cancer Center |
2004-12 | PHASE2 |
| NCT01300572 | COMPLETED | Chronic Myelomonocytic Leukemia; Previously Treated Myelodysplastic Syndrome; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Refractory Anemia With Excess Blasts; Secondary Acute Myeloid Leukemia |
Fred Hutchinson Cancer Center |
2012-01 | PHASE1 |
| NCT00003270 | COMPLETED | Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes |
Roswell Park Cancer Institute |
1997-09-04 | PHASE2 |
| NCT01289301 | UNKNOWN | Disorder Related to Renal Transplantation; Immunosuppression Related Infectious Disease; Virus Diseases |
Hannover Medical School |
2011-10 | PHASE4 |
| NCT02864706 | COMPLETED | Heart Transplantation |
Novartis Pharmaceuticals |
2016-01-18 | PHASE4 |
| NCT00397813 | COMPLETED | Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative; Chronic Myelomonocytic Leukemia; de Novo Myelodysplastic Syndrome; Essential Thrombocythemia; Myeloproliferative Neoplasm; Paroxysmal Nocturnal Hemoglobinuria; Polycythemia Vera; Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase; Primary Myelofibrosis; Refractory Anemia; Refractory Anemia With Excess Blasts; Refractory Anemia With Ring Sideroblasts; Refractory Cytopenia With Multilineage Dysplasia; Refractory Cytopenia With Multilineage Dysplasia and Ring Sideroblasts |
Fred Hutchinson Cancer Center |
2006-01 | PHASE2 |
| NCT03136237 | COMPLETED | Hereditary Angioedema |
BioCryst Pharmaceuticals |
2017-02-17 | PHASE1 |
| NCT02496975 | WITHDRAWN | Traumatic Brain Injury |
Edward Hall,PhD |
2017-08-07 | PHASE1; PHASE2 |
| NCT02653196 | TERMINATED | Neuroepithelial Tumor; Solid Tumor; Allogeneic Hematopoietic Stem Cell Transplantation |
Montefiore Medical Center |
2015-09 | EARLY_PHASE1 |
| NCT00987480 | COMPLETED | Aplastic Anemia; Leukemia; Myelodysplastic Syndrome |
Memorial Sloan Kettering Cancer Center |
2009-09-25 | PHASE2 |
| NCT02934217 | COMPLETED | ST Elevation Acute Myocardial Infarction |
Hospices Civils de Lyon |
2014-03 | PHASE3 |
| NCT03083782 | COMPLETED | Venous Thromboembolism; Pharmacokinetics; Healthy |
Thomas Jefferson University |
2017-04-18 | PHASE1 |
| NCT03812419 | COMPLETED | Kidney Transplant; Complications |
Future University in Egypt |
2016-01-05 | |
| NCT00974142 | COMPLETED | Chronic Obstructive Pulmonary Disease |
Michael Donahoe |
2009-09 | PHASE1; PHASE2 |
| NCT02478424 | UNKNOWN | Graft vs Host Disease |
Rabin Medical Center |
2015-07 | PHASE2 |
| NCT01648270 | COMPLETED | Healthy |
Washington University School of Medicine |
2012-04 | |
| NCT00686556 | COMPLETED | Acute Lymphoblastic Leukemia; Myelodysplastic Syndrome; Multiple Myeloma |
Masonic Cancer Center, University of Minnesota |
2012-08 | PHASE1 |
| NCT00793572 | COMPLETED | Refractory Plasma Cell Myeloma |
Fred Hutchinson Cancer Center |
2008-10 | PHASE2 |
| NCT02203396 | COMPLETED | Aplastic Anemia |
Institute of Hematology & Blood Diseases Hospital, China |
2014-08 | PHASE2 |
| NCT02004067 | COMPLETED | Primary Sjogren Syndrome; Secondary Sjogren Syndrome; Aqueous Deficient Dry Eye Disease; Evaporative Dry Eye Disease |
Federal University of São Paulo |
2013-01 | PHASE4 |
| NCT02404025 | COMPLETED | Aplastic Anemia |
Novartis Pharmaceuticals |
2015-05-12 | PHASE2 |
| NCT01760096 | UNKNOWN | Paroxysmal Nocturnal Hemoglobinuria; Hemoglobinuria; Hemoglobinuria, Paroxysmal; Proteinuria; Urination Disorders; Thrombosis; Bone Marrow Failure; Aplastic Anemia,; Anemia, Hemolytic |
Institute of Hematology & Blood Diseases Hospital, China |
2013-01 | PHASE2 |
| NCT01392989 | COMPLETED | Neural Tube Defects; Anemia; Leukemia, Myeloid; Bone Marrow Transplant Failure; Myelodysplastic Syndromes (MDS); Myeloproliferative Disorders |
Everett Meyer |
2011-03 | PHASE2 |
| NCT00553202 | COMPLETED | Leukemia |
Children's Oncology Group |
2008-01 | PHASE2 |
| NCT01598987 | COMPLETED | Renal Function; Liver Transplant |
Novartis Pharmaceuticals |
2012-10 | PHASE3 |
| NCT02547714 | COMPLETED | Plaque Psoriasis |
Novartis Pharmaceuticals |
2015-06-16 | PHASE4 |
| NCT00110110 | UNKNOWN | Retinoblastoma |
The Hospital for Sick Children |
2004-06 | PHASE2 |
| NCT02554981 | COMPLETED | Dry Eye Syndromes |
Allergan |
2015-07-21 | PHASE4 |
| NCT02655705 | COMPLETED | Psoriasis |
Seoul National University Hospital |
2014-08 | PHASE4 |
| NCT01751126 | COMPLETED | Vernal Keratoconjunctivitis |
Santen SAS |
2013-04-29 | PHASE3 |
| NCT02144025 | COMPLETED | Graft-Versus-Host Disease |
Hospital Universitario Dr. Jose E. Gonzalez |
2014-05 | PHASE2 |
| NCT00005803 | COMPLETED | Prolymphocytic Leukemia; Recurrent Adult Hodgkin Lymphoma; Recurrent Childhood Hodgkin Lymphoma; Recurrent Childhood Non-Hodgkin Lymphoma; Recurrent Chronic Lymphocytic Leukemia; Recurrent Non-Hodgkin Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory Childhood Hodgkin Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Hodgkin Lymphoma; Refractory Non-Hodgkin Lymphoma; Refractory Small Lymphocytic Lymphoma; T-Cell Chronic Lymphocytic Leukemia; T-Cell Prolymphocytic Leukemia |
Fred Hutchinson Cancer Center |
1999-09 | PHASE1; PHASE2 |
| NCT04714099 | COMPLETED | Dry Eye |
Alexandria University |
2015-01-01 | PHASE3 |
| NCT01093586 | COMPLETED | Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Megakaryoblastic Leukemia (M7); Adult Acute Minimally Differentiated Myeloid Leukemia (M0); Adult Acute Monoblastic Leukemia (M5a); Adult Acute Monocytic Leukemia (M5b); Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Erythroleukemia (M6a); Adult Nasal Type Extranodal NK/T-cell Lymphoma; Adult Pure Erythroid Leukemia (M6b); B-cell Adult Acute Lymphoblastic Leukemia; B-cell Childhood Acute Lymphoblastic Leukemia; Blastic Phase Chronic Myelogenous Leukemia; Burkitt Lymphoma; Childhood Acute Erythroleukemia (M6); Childhood Acute Lymphoblastic Leukemia in Remission; Childhood Acute Megakaryocytic Leukemia (M7); Childhood Acute Minimally Differentiated Myeloid Leukemia (M0); Childhood Acute Monoblastic Leukemia (M5a); Childhood Acute Monocytic Leukemia (M5b); Childhood Acute Myeloid Leukemia in Remission; Childhood Chronic Myelogenous Leukemia; Childhood Diffuse Large Cell Lymphoma; Childhood Immunoblastic Large Cell Lymphoma; Childhood Myelodysplastic Syndromes; Childhood Nasal Type Extranodal NK/T-cell Lymphoma; Chronic Myelomonocytic Leukemia; Chronic Phase Chronic Myelogenous Leukemia; Cutaneous B-cell Non-Hodgkin Lymphoma; de Novo Myelodysplastic Syndromes; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Juvenile Myelomonocytic Leukemia; Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Nodal Marginal Zone B-cell Lymphoma; Previously Treated Myelodysplastic Syndromes; Prolymphocytic Leukemia; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Recurrent Childhood Anaplastic Large Cell Lymphoma; Recurrent Childhood Grade III Lymphomatoid Granulomatosis; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Small Noncleaved Cell Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Relapsing Chronic Myelogenous Leukemia; Secondary Acute Myeloid Leukemia; Secondary Myelodysplastic Syndromes; Secondary Myelofibrosis; Splenic Marginal Zone Lymphoma; Stage I Chronic Lymphocytic Leukemia; Stage II Chronic Lymphocytic Leukemia; Stage III Chronic Lymphocytic Leukemia; Stage IV Chronic Lymphocytic Leukemia; T-cell Adult Acute Lymphoblastic Leukemia; T-cell Childhood Acute Lymphoblastic Leukemia; T-cell Large Granular Lymphocyte Leukemia; Waldenstrom Macroglobulinemia |
Case Comprehensive Cancer Center |
2007-09 | PHASE2 |
| NCT00972660 | UNKNOWN | Graft Versus Host Disease |
Guangdong Provincial People's Hospital |
2009-09 | PHASE2 |
| NCT00944749 | COMPLETED | Anemia, Aplastic; Anemia, Hypoplastic |
National Heart, Lung, and Blood Institute (NHLBI) |
2009-08-31 | PHASE2 |
| NCT01410448 | COMPLETED | Kidney Transplantation |
Novartis Pharmaceuticals |
2011-11 | PHASE3 |
| NCT02034747 | COMPLETED | Kidney Transplant |
Astellas Pharma Korea, Inc. |
2013-11-21 | PHASE4 |
| NCT00520130 | COMPLETED | Myelodysplastic Syndrome; Hodgkin's Lymphoma; Non-Hodgkin's Disease; Acute Leukemia; Multiple Myeloma |
National Cancer Institute (NCI) |
2007-10-30 | PHASE1; PHASE2 |
| NCT01901471 | WITHDRAWN | Acute Myocardial Infarction |
Hospices Civils de Lyon |
2015-09 | PHASE2 |
| NCT01762657 | WITHDRAWN | Type 1 Diabetes |
Perle Bioscience, Inc. |
2014-09 | PHASE3 |
| NCT01650545 | COMPLETED | Disorder Related to Lung Transplantation; Bronchiolitis Obliterans; Decreased Immunologic Activity; Chronic Rejection of Lung Transplant |
University of Maryland, Baltimore |
2012-07 | PHASE1; PHASE2 |
| NCT00245037 | COMPLETED | Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Precancerous Condition |
OHSU Knight Cancer Institute |
2005-06 | PHASE1; PHASE2 |
| NCT02496494 | UNKNOWN | CYCLOSPORINE/TACROLIMUS |
Kyungpook National University Hospital |
2012-09 | PHASE4 |
| NCT01020734 | COMPLETED | Leukemia |
Asan Medical Center |
2011-05 | PHASE2 |
| NCT02314312 | UNKNOWN | Transplantation of Kidney; Expanded Criteria Donor; ECD |
Mahidol University |
2012-01 | PHASE3 |
| NCT01938625 | COMPLETED | Hepatitis C, Chronic |
Janssen R&D Ireland |
2013-12-12 | PHASE2 |
| NCT01469884 | COMPLETED | Renal Allograft; Hepatitis C |
Irmandade Santa Casa de Misericórdia de Porto Alegre |
2011-11 | PHASE4 |
| NCT02268201 | TERMINATED | Kidney Transplant Recipients |
Astellas Pharma China, Inc. |
2013-07-23 | PHASE4 |
| NCT00993343 | COMPLETED | Graft-versus-host Disease; Survival |
Karolinska Institutet |
2007-09 | PHASE3 |
| NCT00096161 | COMPLETED | Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Chronic Lymphocytic Leukemia; Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Graft Versus Host Disease; Hodgkin Lymphoma; Myelodysplastic/Myeloproliferative Neoplasm; Non-Hodgkin Lymphoma; Plasma Cell Myeloma; Waldenstrom Macroglobulinemia |
Fred Hutchinson Cancer Center |
2003-05 | PHASE2 |
| NCT01502774 | COMPLETED | ST Elevation Acute Myocardial Infarction |
Hospices Civils de Lyon |
2011-04 | PHASE3 |
| NCT02130414 | COMPLETED | Healthy |
Sigmoid Pharma |
2014-07 | PHASE1 |
| NCT00755040 | COMPLETED | Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms |
Vanderbilt-Ingram Cancer Center |
2008-10 | PHASE3 |
| NCT01149759 | COMPLETED | Atopic Dermatitis; Eczema |
Rockefeller University |
2010-06 | |
| NCT01446484 | UNKNOWN | End-Stage Renal Disease; Kidney Failure |
Pirogov Russian National Research Medical University |
2011-10 | PHASE1; PHASE2 |
| NCT00928018 | COMPLETED | Non-hodgkin Lymphoma; Hodgkin Lymphoma |
Dana-Farber Cancer Institute |
2009-06 | PHASE3 |
| NCT02114073 | COMPLETED | Glaucoma, Open Angle |
Mashhad University of Medical Sciences |
2014-04 | PHASE2 |
| NCT01693393 | COMPLETED | Sjögren´s Syndrome |
Charite University, Berlin, Germany |
2010-03 | PHASE2 |
| NCT00051311 | COMPLETED | Hematologic Neoplasms |
National Cancer Institute (NCI) |
2003-01-03 | PHASE2 |
| NCT00383448 | COMPLETED | Adrenoleukodystrophy; Metachromatic Leukodystrophy; Globoid Cell Leukodystrophy; Tay Sachs Disease; Sandhoffs Disease; Wolman Disease; I-Cell Disease; Sanfilippo Syndrome; GM1 Gangliosidosis |
Masonic Cancer Center, University of Minnesota |
2006-09 | PHASE2 |
| NCT01193283 | COMPLETED | Aplastic Anemia; Neutropenia; Pancytopenia; Severe Aplastic Anemia |
National Heart, Lung, and Blood Institute (NHLBI) |
2010-08 | PHASE1; PHASE2 |
| NCT01175785 | COMPLETED | Accelerated Phase Chronic Myelogenous Leukemia; Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Childhood Acute Lymphoblastic Leukemia in Remission; Childhood Acute Myeloid Leukemia in Remission; Childhood Chronic Myelogenous Leukemia; Childhood Myelodysplastic Syndromes; Chronic Phase Chronic Myelogenous Leukemia; de Novo Myelodysplastic Syndromes; Previously Treated Myelodysplastic Syndromes; Refractory Anemia; Refractory Anemia With Excess Blasts; Refractory Anemia With Excess Blasts in Transformation; Relapsing Chronic Myelogenous Leukemia; Secondary Myelodysplastic Syndromes |
Nohla Therapeutics, Inc. |
2010-08 | PHASE2 |
| NCT00119366 | TERMINATED | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Childhood Myelodysplastic Syndromes; Chronic Myelomonocytic Leukemia; Previously Treated Myelodysplastic Syndromes; Recurrent Adult Acute Myeloid Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Refractory Anemia With Excess Blasts; Refractory Anemia With Excess Blasts in Transformation; Refractory Anemia With Ringed Sideroblasts; Refractory Cytopenia With Multilineage Dysplasia; Secondary Acute Myeloid Leukemia; Secondary Myelodysplastic Syndromes |
Fred Hutchinson Cancer Center |
2003-05 | PHASE2 |
| NCT02276001 | COMPLETED | Healthy |
Kowa Research Institute, Inc. |
2014-06 | PHASE1 |
| NCT01023542 | UNKNOWN | Renal Impairment; Liver Transplantation; Everolimus |
University of Regensburg |
2011-06 | PHASE2; PHASE3 |
| NCT00036738 | COMPLETED | Adult Acute Lymphoblastic Leukemia in Remission; Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Blastic Phase; Childhood Acute Lymphoblastic Leukemia in Remission; Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Chronic Phase of Disease; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Disease |
Fred Hutchinson Cancer Center |
2001-07-13 | PHASE2 |
| NCT02113293 | COMPLETED | Healthy |
Novaliq GmbH |
2014-03 | PHASE1 |
| NCT00185640 | COMPLETED | Blood Cancer; Leukemia |
Stanford University |
2003-03 | PHASE2 |
| NCT00387959 | COMPLETED | Leukemia; Lymphoma |
Memorial Sloan Kettering Cancer Center |
2006-07 | PHASE2 |
| NCT02016625 | COMPLETED | Healthy |
Boehringer Ingelheim |
2013-12 | PHASE1 |
| NCT02229955 | COMPLETED | Dry Eye Syndromes |
Hanlim Pharm. Co., Ltd. |
2013-12 | PHASE3 |
| NCT01105650 | COMPLETED | Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer; Breast Cancer |
Masonic Cancer Center, University of Minnesota |
2010-07 | PHASE2 |
| NCT01789255 | COMPLETED | Accelerated Phase Chronic Myelogenous Leukemia; Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Grade III Lymphomatoid Granulomatosis; B-cell Chronic Lymphocytic Leukemia; Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Chronic Myelomonocytic Leukemia; Chronic Phase Chronic Myelogenous Leukemia; Contiguous Stage II Adult Burkitt Lymphoma; Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Contiguous Stage II Adult Lymphoblastic Lymphoma; Contiguous Stage II Grade 1 Follicular Lymphoma; Contiguous Stage II Grade 2 Follicular Lymphoma; Contiguous Stage II Grade 3 Follicular Lymphoma; Contiguous Stage II Mantle Cell Lymphoma; Contiguous Stage II Marginal Zone Lymphoma; Contiguous Stage II Small Lymphocytic Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Graft Versus Host Disease; Intraocular Lymphoma; Myelodysplastic Syndrome With Isolated Del(5q); Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Burkitt Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Noncontiguous Stage II Adult Lymphoblastic Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Grade 3 Follicular Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Noncontiguous Stage II Marginal Zone Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Post-transplant Lymphoproliferative Disorder; Primary Central Nervous System Hodgkin Lymphoma; Primary Central Nervous System Non-Hodgkin Lymphoma; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory Anemia; Refractory Anemia With Excess Blasts; Refractory Anemia With Ringed Sideroblasts; Refractory Chronic Lymphocytic Leukemia; Refractory Cytopenia With Multilineage Dysplasia; Refractory Hairy Cell Leukemia; Relapsing Chronic Myelogenous Leukemia; Secondary Central Nervous System Hodgkin Lymphoma; Secondary Central Nervous System Non-Hodgkin Lymphoma; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Stage I Adult Burkitt Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Stage I Adult Diffuse Mixed Cell Lymphoma; Stage I Adult Diffuse Small Cleaved Cell Lymphoma; Stage I Adult Hodgkin Lymphoma; Stage I Adult Immunoblastic Large Cell Lymphoma; Stage I Adult Lymphoblastic Lymphoma; Stage I Chronic Lymphocytic Leukemia; Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Grade 3 Follicular Lymphoma; Stage I Mantle Cell Lymphoma; Stage I Marginal Zone Lymphoma; Stage I Small Lymphocytic Lymphoma; Stage II Adult Hodgkin Lymphoma; Stage II Chronic Lymphocytic Leukemia; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Hodgkin Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Chronic Lymphocytic Leukemia; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Hodgkin Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Small Lymphocytic Lymphoma; Testicular Lymphoma; Waldenström Macroglobulinemia |
National Cancer Institute (NCI) |
2013-06 | PHASE2 |
| NCT00412360 | COMPLETED | Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia; Chronic Myelogenous Leukemia; Myelodysplastic Syndrome; Natural Killer Cell Lymphoblastic Leukemia/Lymphoma |
Medical College of Wisconsin |
2006-12 | PHASE3 |
| NCT01804361 | COMPLETED | Dry Eye Syndromes |
DH Bio Co., Ltd. |
2013-03 | PHASE3 |
| NCT00317408 | UNKNOWN | Lymphoma |
European Inter-group Cooperation on Childhood and Adolescent Non Hodgkin Lymphoma |
2004-04 | |
| NCT00075478 | COMPLETED | Acute Lymphoblastic Leukemia in Remission; Acute Myeloid Leukemia in Remission; Aggressive Non-Hodgkin Lymphoma; Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Diffuse Large B-Cell Lymphoma; Hematopoietic and Lymphoid Cell Neoplasm; Indolent Non-Hodgkin Lymphoma; Mantle Cell Lymphoma; Myelodysplastic/Myeloproliferative Neoplasm; Plasma Cell Myeloma; Refractory Chronic Lymphocytic Leukemia; Refractory Hodgkin Lymphoma; Waldenstrom Macroglobulinemia |
Fred Hutchinson Cancer Center |
2003-10 | PHASE3 |
| NCT01170351 | COMPLETED | Autoimmune Hepatitis |
Tehran University of Medical Sciences |
2005-12 | PHASE3 |
| NCT01598688 | COMPLETED | Hematopoietic Stem Cell Transplantation |
University of Sao Paulo |
2012-02 | |
| NCT01699360 | UNKNOWN | Kidney Transplantation |
Central South University |
2012-09 | PHASE4 |
| NCT01552629 | COMPLETED | Atopic Dermatitis |
Novartis Pharmaceuticals |
2012-01-05 | PHASE2 |
| NCT01758107 | UNKNOWN | Renal Transplant |
Chulalongkorn University |
2010-08 | PHASE4 |
| NCT00789308 | COMPLETED | Diabetes Mellitus, Type I |
National Institute of Allergy and Infectious Diseases (NIAID) |
2008-07-11 | PHASE2 |
| NCT01109498 | UNKNOWN | Familial Lipoprotein Lipase Deficiency |
Amsterdam Molecular Therapeutics |
2007-08 | PHASE2; PHASE3 |
| NCT02108301 | UNKNOWN | Chronic Hepatitis C-virus Infection; Renal Transplantation |
Prof. Dr. Alice Schmidt |
2011-12 | PHASE4 |
| NCT00377325 | WITHDRAWN | Psoriasis |
University of Rochester |
2007-06 | PHASE2 |
| NCT00453388 | COMPLETED | Acute Myeloid Leukemia in Remission; de Novo Myelodysplastic Syndrome; Fanconi Anemia; Previously Treated Myelodysplastic Syndrome |
Fred Hutchinson Cancer Center |
2007-02 | PHASE2 |
| NCT00983424 | COMPLETED | Metastatic Breast Cancer |
Northwestern University |
2010-02 | PHASE1 |
| NCT01129739 | UNKNOWN | Myelodysplastic Syndromes |
Shandong University |
2010-05 | PHASE2 |
| NCT01497483 | COMPLETED | Healthy |
University of California, San Francisco |
2011-12 | PHASE1 |
| NCT00634920 | COMPLETED | Renal Function |
Novartis Pharmaceuticals |
2008-03 | PHASE4 |
| NCT01596062 | COMPLETED | Renal Transplantation |
Novartis Pharmaceuticals |
2012-03 | PHASE2 |
| NCT00255684 | TERMINATED | Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms |
University of Rochester |
2003-12 | |
| NCT01595958 | COMPLETED | Non Shockable Out of Hospital Cardiac Arrest |
Hospices Civils de Lyon |
2010-06 | PHASE3 |
| NCT01266148 | COMPLETED | Renal Function and Chronic Allograft Vasculopathy |
Novartis Pharmaceuticals |
2009-11 | PHASE4 |
| NCT01235910 | TERMINATED | Hypertension; Cardiac Transplantation |
University of Colorado, Denver |
2011-05 | PHASE4 |
| NCT01654211 | COMPLETED | Healthy Volunteer |
Hoffmann-La Roche |
2012-07 | PHASE1 |
| NCT02963103 | TERMINATED | Kidney Transplantation |
Astellas Pharma Korea, Inc. |
2010-05 | PHASE4 |
| NCT00741338 | COMPLETED | Mucopolysaccharidosis I |
Genzyme, a Sanofi Company |
2008-09 | PHASE1; PHASE2 |
| NCT00959231 | UNKNOWN | Hematopoietic/Lymphoid Cancer |
Cancer Research UK |
2009-01 | PHASE2 |
| NCT00820911 | COMPLETED | Kidney Transplantation |
Novartis Pharmaceuticals |
2008-09 | PHASE2 |
| NCT01023815 | COMPLETED | de Novo Kidney Transplant Recipients; Renal Transplantation |
Novartis |
2009-04 | PHASE3 |
| NCT00343785 | COMPLETED | Aplastic Anemia |
Fred Hutchinson Cancer Center |
2006-02 | PHASE2 |
| NCT00350545 | COMPLETED | Graft vs Host Disease |
Stanford University |
2006-08 | |
| NCT00322101 | COMPLETED | Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome; Acute Myeloid Leukemia/Transient Myeloproliferative Disorder; Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Childhood Acute Myeloid Leukemia in Remission; Childhood Myelodysplastic Syndromes; de Novo Myelodysplastic Syndromes; Myelodysplastic Syndrome With Isolated Del(5q); Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Previously Treated Myelodysplastic Syndromes; Recurrent Adult Acute Myeloid Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Secondary Acute Myeloid Leukemia; Secondary Myelodysplastic Syndromes |
Fred Hutchinson Cancer Center |
2006-01 | PHASE3 |
| NCT01342887 | TERMINATED | Adult Acute Megakaryoblastic Leukemia (M7); Adult Acute Minimally Differentiated Myeloid Leukemia (M0); Adult Acute Monoblastic Leukemia (M5a); Adult Acute Monocytic Leukemia (M5b); Adult Acute Myeloblastic Leukemia With Maturation (M2); Adult Acute Myeloblastic Leukemia Without Maturation (M1); Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Acute Myelomonocytic Leukemia (M4); Adult Erythroleukemia (M6a); Adult Pure Erythroid Leukemia (M6b); Recurrent Adult Acute Myeloid Leukemia |
Fred Hutchinson Cancer Center |
2011-04 | PHASE1; PHASE2 |
| NCT01437384 | COMPLETED | Idiopathic Thrombocytopenic Purpura (ITP) |
Eisai Inc. |
2011-09 | PHASE1 |
| NCT01514968 | COMPLETED | Healthy Volunteer |
Hoffmann-La Roche |
2011-12 | PHASE1 |
| NCT01160276 | COMPLETED | Renal Replacement Therapies |
Assistance Publique - Hôpitaux de Paris |
2010-05 | PHASE1 |
| NCT01288131 | TERMINATED | Anti-r-HuEpo Associated PRCA Subjects |
Chulalongkorn University |
2009-01 | PHASE3 |
| NCT00008450 | COMPLETED | Adenosine Deaminase Deficiency; Autosomal Recessive Disorder; Immune System Disorder; Purine-Nucleoside Phosphorylase Deficiency; Severe Combined Immunodeficiency; Severe Combined Immunodeficiency With Absence of T and B Cells; X-Linked Severe Combined Immunodeficiency |
Fred Hutchinson Cancer Center |
1997-08-11 | PHASE1 |
| NCT00809172 | COMPLETED | Atopic Dermatitis |
Hospices Civils de Lyon |
2008-12 | PHASE3 |
| NCT00301834 | COMPLETED | Congenital Amegakaryocytic Thrombocytopenia; Diamond-blackfan Anemia; Leukemia; Myelodysplastic Syndromes; Severe Congenital Neutropenia |
University of California, San Francisco |
2005-01 | PHASE2 |
| NCT01064830 | COMPLETED | Brittle Nail Syndrome |
University of North Carolina, Chapel Hill |
2010-02 | PHASE2 |
| NCT00300274 | COMPLETED | Graft Rejection |
Novartis Pharmaceuticals |
2006-01 | PHASE3 |
| NCT01370343 | COMPLETED | Healthy; Drug Interaction |
Pfizer |
2011-07 | PHASE1 |
| NCT00323960 | COMPLETED | Juvenile Dermatomyositis |
Istituto Giannina Gaslini |
2006-05-31 | PHASE3 |
| NCT01109056 | COMPLETED | Pterygium |
Allergan |
2010-06 | PHASE2 |
| NCT01002859 | TERMINATED | Coronary Artery Bypass Surgery; Cardiopulmonary Bypass |
University Hospital, Grenoble |
2009-04 | PHASE2 |
| NCT00504543 | COMPLETED | Kidney Transplantation |
Novartis Pharmaceuticals |
2007-07 | PHASE2 |
| NCT01718652 | COMPLETED | Healthy |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
2011-02 | PHASE1 |
| NCT00553735 | TERMINATED | Dry Eye |
Massachusetts Eye and Ear Infirmary |
2007-08 | PHASE4 |
| NCT01231841 | COMPLETED | Aplastic Anemia |
The Cleveland Clinic |
2005-03 | PHASE2 |
| NCT00840827 | TERMINATED | Myelodysplastic Syndrome |
Weill Medical College of Cornell University |
2008-12 | PHASE2 |
| NCT00354419 | TERMINATED | Aplastic Anemia |
Fred Hutchinson Cancer Center |
2006-02 | PHASE1 |
| NCT00334672 | UNKNOWN | Nonneoplastic Condition |
Children's Cancer and Leukaemia Group |
2006-03 | PHASE3 |
| NCT00186628 | COMPLETED | Leukemia, Mast-Cell; Mantle-cell Lymphoma |
Stanford University |
2005-06 | PHASE2 |
| NCT00705510 | COMPLETED | Meibomian Gland Dysfunction |
Mahidol University |
2008-05 | PHASE4 |
| NCT00884585 | COMPLETED | Atopic Conjunctivitis |
Allergan |
2009-05 | PHASE3 |
| NCT00060424 | COMPLETED | B-Cell Prolymphocytic Leukemia; Chronic Lymphocytic Leukemia; Prolymphocytic Leukemia; Recurrent Chronic Lymphocytic Leukemia; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; T-Cell Prolymphocytic Leukemia |
Fred Hutchinson Cancer Center |
2003-03 | PHASE2 |
| NCT00891306 | COMPLETED | Familial Lipoprotein Lipase Deficiency |
Amsterdam Molecular Therapeutics |
2009-02 | PHASE2; PHASE3 |
| NCT01120132 | COMPLETED | Allergic Conjunctivitis |
Fovea Pharmaceuticals SA |
2010-05 | PHASE2 |
| NCT00986427 | COMPLETED | Brittle Nails |
Julian M. Mackay-Wiggan |
2009-07 | PHASE2 |
| NCT00609739 | TERMINATED | Leukemia |
Masonic Cancer Center, University of Minnesota |
1999-06 | PHASE1; PHASE2 |
| NCT00903188 | UNKNOWN | Renal Transplantation |
University Hospital, Antwerp |
2008-10 | PHASE4 |
| NCT00112645 | COMPLETED | Neuroblastoma; Sarcoma; Unspecified Childhood Solid Tumor, Protocol Specific |
Milton S. Hershey Medical Center |
2005-04 | PHASE1 |
| NCT01038167 | COMPLETED | Hepatitis C |
Vertex Pharmaceuticals Incorporated |
2010-01 | PHASE1 |
| NCT02660684 | COMPLETED | Graft Versus Host Disease |
Astellas Pharma Korea, Inc. |
2008-02 | PHASE4 |
| NCT01692834 | COMPLETED | Healthy |
NeuroVive Pharmaceutical AB |
2009-06 | PHASE1 |
| NCT00740467 | UNKNOWN | Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Precancerous Condition |
Institut Paoli-Calmettes |
2008-01 | PHASE2 |
| NCT00040846 | COMPLETED | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Childhood Burkitt Lymphoma; Childhood Chronic Myelogenous Leukemia; Childhood Diffuse Large Cell Lymphoma; Childhood Immunoblastic Large Cell Lymphoma; Childhood Nasal Type Extranodal NK/T-cell Lymphoma; Chronic Phase Chronic Myelogenous Leukemia; Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Contiguous Stage II Grade 1 Follicular Lymphoma; Contiguous Stage II Grade 2 Follicular Lymphoma; Contiguous Stage II Marginal Zone Lymphoma; Contiguous Stage II Small Lymphocytic Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Marginal Zone Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Peripheral T-cell Lymphoma; Previously Treated Myelodysplastic Syndromes; Progressive Hairy Cell Leukemia, Initial Treatment; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Recurrent Childhood Anaplastic Large Cell Lymphoma; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Small Noncleaved Cell Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Recurrent/Refractory Childhood Hodgkin Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Hairy Cell Leukemia; Refractory Multiple Myeloma; Relapsing Chronic Myelogenous Leukemia; Splenic Marginal Zone Lymphoma; Stage I Adult Diffuse Small Cleaved Cell Lymphoma; Stage I Childhood Anaplastic Large Cell Lymphoma; Stage I Childhood Large Cell Lymphoma; Stage I Cutaneous T-cell Non-Hodgkin Lymphoma; Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Mantle Cell Lymphoma; Stage I Marginal Zone Lymphoma; Stage I Mycosis Fungoides/Sezary Syndrome; Stage I Small Lymphocytic Lymphoma; Stage II Childhood Anaplastic Large Cell Lymphoma; Stage II Childhood Large Cell Lymphoma; Stage II Cutaneous T-cell Non-Hodgkin Lymphoma; Stage II Mycosis Fungoides/Sezary Syndrome; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Childhood Anaplastic Large Cell Lymphoma; Stage III Childhood Large Cell Lymphoma; Stage III Cutaneous T-cell Non-Hodgkin Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Mycosis Fungoides/Sezary Syndrome; Stage III Small Lymphocytic Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Childhood Anaplastic Large Cell Lymphoma; Stage IV Childhood Large Cell Lymphoma; Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Mycosis Fungoides/Sezary Syndrome; Stage IV Small Lymphocytic Lymphoma; T-cell Large Granular Lymphocyte Leukemia; Waldenström Macroglobulinemia |
Fred Hutchinson Cancer Center |
2001-11 | PHASE2 |
| NCT00547196 | COMPLETED | Leukemia; Lymphoma; Myelodysplastic Syndromes |
City of Hope Medical Center |
2005-08-16 | |
| NCT00054353 | COMPLETED | Refractory Multiple Myeloma |
Fred Hutchinson Cancer Center |
2002-10 | PHASE1; PHASE2 |
| NCT00784719 | COMPLETED | Dry Eye Syndromes |
Pfizer |
2008-11 | PHASE1; PHASE2 |
| NCT00790439 | WITHDRAWN | Diabetes Mellitus, Type I |
National Institute of Allergy and Infectious Diseases (NIAID) |
2008-07 | PHASE2 |
| NCT00251004 | COMPLETED | Kidney Transplantation; Graft Rejection |
Novartis |
2005-10 | PHASE3 |
| NCT00795132 | COMPLETED | Acute Leukaemia; Chronic Disease; Leukemia; Myelodysplasia; Lymphoma |
University of Utah |
2004-04 | PHASE2 |
| NCT00119392 | COMPLETED | B-cell Chronic Lymphocytic Leukemia; Nodal Marginal Zone B-cell Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Splenic Marginal Zone Lymphoma; Waldenström Macroglobulinemia |
Fred Hutchinson Cancer Center |
2004-06 | PHASE2 |
| NCT00419926 | COMPLETED | Kidney Transplantation |
Novartis |
2006-12 | PHASE4 |
| NCT00481481 | COMPLETED | Transplantation |
Astellas Pharma Inc |
2007-04 | PHASE3 |
| NCT00027560 | COMPLETED | Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms |
Memorial Sloan Kettering Cancer Center |
2001-07 | PHASE2 |
| NCT00185614 | COMPLETED | Blood Cancer; Multiple Myeloma |
Wen-Kai Weng |
2000-08 | PHASE2 |
| NCT00413920 | COMPLETED | Renal Transplantation |
Novartis |
2007-04 | PHASE3 |
| NCT00149890 | COMPLETED | Liver Transplantation; Infection |
Novartis |
2004-03 | PHASE3 |
| NCT02005562 | COMPLETED | Kidney Transplantation |
Hoffmann-La Roche |
2006-05 | PHASE3 |
| NCT00070291 | TERMINATED | Lymphoma |
Eastern Cooperative Oncology Group |
2006-01-24 | PHASE2 |
| NCT02091414 | COMPLETED | Heart Transplantation |
Hoffmann-La Roche |
2006-08 | PHASE3 |
| NCT00739349 | COMPLETED | Dry Eye |
Santen SAS |
2008-08 | PHASE2 |
| NCT00045435 | COMPLETED | Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome; Adult Acute Megakaryoblastic Leukemia (M7); Adult Acute Minimally Differentiated Myeloid Leukemia (M0); Adult Acute Monoblastic Leukemia (M5a); Adult Acute Monocytic Leukemia (M5b); Adult Acute Myeloblastic Leukemia With Maturation (M2); Adult Acute Myeloblastic Leukemia Without Maturation (M1); Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Acute Myelomonocytic Leukemia (M4); Adult Erythroleukemia (M6a); Adult Pure Erythroid Leukemia (M6b); Secondary Acute Myeloid Leukemia |
Fred Hutchinson Cancer Center |
2002-04 | PHASE2 |
| NCT00129961 | COMPLETED | Skin Neoplasms; Kidney Transplantation |
Wyeth is now a wholly owned subsidiary of Pfizer |
2005-08 | PHASE4 |
| NCT00420537 | TERMINATED | Kidney Dysfunction; Heart Transplantation |
University of Bologna |
2006-09 | PHASE4 |
| NCT00079391 | COMPLETED | Hematologic Malignancies; Bone Marrow Transplant Rejection |
National Heart, Lung, and Blood Institute (NHLBI) |
2004-01 | PHASE2 |
| NCT00478608 | COMPLETED | Renal Transplant |
Wyeth is now a wholly owned subsidiary of Pfizer |
2007-03 | PHASE3 |
| NCT00594308 | TERMINATED | Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia; Chronic Myelogenous Leukemia; Chronic Lymphocytic Leukemia; Myelodysplasia; Lymphoma, Non-Hodgkin's; Mantle-Cell Lymphoma; Hodgkin's Disease; Multiple Myeloma; Myelofibrosis |
Indiana University |
2007-10 | |
| NCT00399061 | COMPLETED | Dry Eye |
Innovative Medical |
2006-11 | PHASE4 |
| NCT01292226 | COMPLETED | Kidney Transplantation |
Hoffmann-La Roche |
2006-12 | PHASE2 |
| NCT00818194 | COMPLETED | Healthy |
Astellas Pharma Inc |
2008-04 | PHASE1 |
| NCT00349440 | COMPLETED | Dry Eye Syndromes |
Innovative Medical |
2006-09 | PHASE4 |
| NCT00452361 | TERMINATED | Kidney Transplantation |
Wyeth is now a wholly owned subsidiary of Pfizer |
2007-04 | PHASE4 |
| NCT00354172 | TERMINATED | Leukemia; Myelodysplastic Syndromes |
Masonic Cancer Center, University of Minnesota |
2006-02 | PHASE2 |
| NCT00157014 | COMPLETED | Heart Diseases; Heart Transplantation |
Astellas Pharma Inc |
2004-05-10 | PHASE3 |
| NCT00154284 | COMPLETED | Organ Transplantation, Renal Transplantation |
Novartis |
2005-07 | PHASE3 |
| NCT00704275 | UNKNOWN | Dry Eye |
Chulalongkorn University |
2007-06 | PHASE4 |
| NCT00195273 | COMPLETED | Graft vs Host Disease; Kidney Transplantation |
Wyeth is now a wholly owned subsidiary of Pfizer |
2004-11 | PHASE3 |
| NCT00905515 | COMPLETED | Kidney Transplantation |
East Carolina University |
2003-08 | PHASE4 |
| NCT00118742 | COMPLETED | Liver Transplantation |
Hoffmann-La Roche |
2005-08 | PHASE4 |
| NCT00256750 | COMPLETED | Kidney Transplantation; Chronic Kidney Failure |
Bristol-Myers Squibb |
2005-03 | PHASE3 |
| NCT00359814 | COMPLETED | Heart Transplantation |
Hannover Medical School |
2004-11 | |
| NCT00359658 | COMPLETED | Heart Transplantation |
Hannover Medical School |
2004-11 | |
| NCT00309218 | COMPLETED | Kidney Diseases |
Klinik für Kinder- und Jugendmedizin |
1999-03 | PHASE3 |
| NCT00038948 | COMPLETED | Renal Transplantation |
Wyeth is now a wholly owned subsidiary of Pfizer |
2002-01 | PHASE3 |
| NCT00777933 | COMPLETED | Kidney Transplantation; Living Donors |
Samsung Medical Center |
2000-07 | |
| NCT00525681 | COMPLETED | Renal Transplantation |
University of Oslo School of Pharmacy |
2007-09 | PHASE4 |
| NCT00521430 | COMPLETED | Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Nonmalignant Neoplasm; Unspecified Adult Solid Tumor, Protocol Specific |
Asan Medical Center |
2004-04 | |
| NCT00434590 | TERMINATED | Kidney Transplantation |
Novartis Pharmaceuticals |
2007-03 | PHASE4 |
| NCT00332462 | COMPLETED | Liver Transplantation |
Novartis Pharmaceuticals |
2006-05 | PHASE4 |
| NCT00376519 | TERMINATED | Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Secondary Myelofibrosis |
Masonic Cancer Center, University of Minnesota |
2007-05 | PHASE1 |
| NCT00074269 | TERMINATED | Breast Cancer |
University of California, San Diego |
2003-07 | PHASE2 |
| NCT00005937 | COMPLETED | Myelodysplastic Syndrome |
Neal Young, M.D. |
2000-06 | PHASE2 |
| NCT00056095 | COMPLETED | Kidney Cancer |
UNICANCER |
2002-11-04 | PHASE2 |
| NCT00281879 | TERMINATED | Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Unusual Cancers of Childhood |
OHSU Knight Cancer Institute |
2006-02 | PHASE2 |
| NCT00006184 | COMPLETED | Multiple Myeloma |
National Cancer Institute (NCI) |
2001-02-08 | PHASE2 |
| NCT00405457 | COMPLETED | Dry Eye |
Innovative Medical |
2006-11 | PHASE4 |
| NCT00337493 | COMPLETED | Kidney Transplantation |
Hoffmann-La Roche |
2005-12 | PHASE4 |
| NCT00084149 | COMPLETED | HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
2004-02 | PHASE2 |
| NCT00001873 | COMPLETED | Chronic Lymphocytic Leukemia; Graft vs Host Disease; Hematologic Neoplasm; Multiple Myeloma; Myelodysplastic Syndrome |
National Heart, Lung, and Blood Institute (NHLBI) |
1999-02-22 | PHASE2 |
| NCT00154193 | COMPLETED | Heart and Lung Transplant |
Novartis Pharmaceuticals |
2004-06 | PHASE4 |
| NCT00003335 | COMPLETED | Graft Versus Host Disease; Leukemia; Lymphoma; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases |
Case Comprehensive Cancer Center |
1998-01 | PHASE2 |
| NCT00087581 | COMPLETED | Kidney Transplantation |
Hoffmann-La Roche |
2004-06 | PHASE4 |
| NCT01080586 | COMPLETED | Healthy Volunteers |
Panacea Biotec Ltd |
2007-09 | |
| NCT00407043 | COMPLETED | Dry Eye Disease; Keratoconjunctivitis Sicca |
Ophthalmic Consultants of Long Island |
2006-11 | PHASE4 |
| NCT00004485 | COMPLETED | Sickle Cell Anemia |
Fred Hutchinson Cancer Center |
1999-12 | PHASE1; PHASE2 |
| NCT00005852 | TERMINATED | Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes |
H. Lee Moffitt Cancer Center and Research Institute |
1996-06 | PHASE2 |
| NCT00170885 | COMPLETED | Kidney Transplantation |
Novartis |
2005-05 | PHASE4 |
| NCT00488436 | COMPLETED | Myelodysplastic Syndrome |
PETHEMA Foundation |
2002-05 | PHASE4 |
| NCT00290628 | TERMINATED | Chronic Myeloproliferative Disorders; Diamond-blackfan Anemia; Fanconi Anemia; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases |
Masonic Cancer Center, University of Minnesota |
1999-10 | |
| NCT00655343 | COMPLETED | Graft vs Host Disease |
Neovii Biotech |
2003-02 | PHASE3 |
| NCT00301860 | TERMINATED | Leukemia; Lymphoma |
University of California, San Francisco |
2003-01 | |
| NCT00105235 | COMPLETED | Liver Disease; Liver Transplantation |
National Institute of Allergy and Infectious Diseases (NIAID) |
2005-06 | PHASE2 |
| NCT00328653 | COMPLETED | Conjunctivitis, Vernal |
Santen SAS |
2006-05 | PHASE2; PHASE3 |
| NCT00537862 | COMPLETED | Kidney Transplant |
Novartis Pharmaceuticals |
2006-05 | PHASE4 |
| NCT00425724 | COMPLETED | Purpura, Schoenlein-Henoch |
Oulu University Hospital |
2000-01 | PHASE4 |
| NCT00049634 | COMPLETED | Chronic Myeloproliferative Disorders; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases |
Fred Hutchinson Cancer Center |
2002-01 | PHASE1; PHASE2 |
| NCT00066794 | COMPLETED | Leukemia |
SWOG Cancer Research Network |
2004-07 | PHASE2 |
| NCT00014508 | COMPLETED | Multiple Myeloma and Plasma Cell Neoplasm |
Eastern Cooperative Oncology Group |
2001-11-19 | PHASE2 |
| NCT00085449 | WITHDRAWN | Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms |
Alliance for Clinical Trials in Oncology |
2006-05 | PHASE1; PHASE2 |
| NCT00195468 | COMPLETED | Kidney Failure; Graft vs Host Disease |
Wyeth is now a wholly owned subsidiary of Pfizer |
2004-03 | PHASE4 |
| NCT00170859 | COMPLETED | Heart Transplantation |
Novartis Pharmaceuticals |
2004-08 | PHASE4 |
| NCT00213590 | COMPLETED | Kidney Transplantation; Primary Prevention; Kidney Failure |
University Hospital, Rouen |
2000-04 | PHASE3 |
| NCT00004208 | COMPLETED | Myelodysplastic Syndromes |
Swiss Cancer Institute |
2000-08 | PHASE3 |
| NCT00948727 | COMPLETED | Hematopoietic Stem Cell Transplantation; Graft Versus Host Disease |
Assistance Publique - Hôpitaux de Paris |
2004-01 | PHASE2 |
| NCT00070174 | COMPLETED | Leukemia |
Children's Oncology Group |
2003-12 | PHASE2 |
| NCT00031655 | COMPLETED | Adult Acute Lymphoblastic Leukemia in Remission; Childhood Acute Lymphoblastic Leukemia in Remission; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Lymphoblastic Leukemia |
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium |
2001-09 | PHASE2 |
| NCT00284921 | TERMINATED | De Novo Kidney Transplant |
Novartis Pharmaceuticals |
2004-04 | PHASE3 |
| NCT00286624 | COMPLETED | Type 1 Diabetes Mellitus; Hypoglycemia |
University of Minnesota |
2003-03 | PHASE1; PHASE2 |
| NCT00170794 | COMPLETED | Cardiac Transplantation |
Novartis Pharmaceuticals |
2004-09 | PHASE3 |
| NCT00856752 | COMPLETED | Pharmacokinetics |
Norgine |
2006-06 | PHASE1 |
| NCT00239863 | COMPLETED | Renal Transplantation |
Novartis Pharmaceuticals |
2004-05 | PHASE3 |
| NCT00239811 | COMPLETED | Renal Transplantation |
Novartis Pharmaceuticals |
2004-04 | PHASE3 |
| NCT00003116 | COMPLETED | Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases |
Case Comprehensive Cancer Center |
1997-05 | PHASE2 |
| NCT00061360 | COMPLETED | Severe Aplastic Anemia |
National Heart, Lung, and Blood Institute (NHLBI) |
2003-06-26 | PHASE2 |
| NCT00171743 | COMPLETED | Liver Transplant |
Novartis |
2004-04 | PHASE4 |
| NCT00005940 | COMPLETED | Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) |
Fred Hutchinson Cancer Center |
1999-10 | PHASE2 |
| NCT00228020 | COMPLETED | Pediatric Kidney Transplantation |
Novartis |
2001-05 | PHASE3 |
| NCT00365287 | COMPLETED | Breast Cancer; Kidney Cancer; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes |
Masonic Cancer Center, University of Minnesota |
2000-06 | PHASE1; PHASE2 |
| NCT01990118 | COMPLETED | End Stage Renal Failure |
Penang Hospital, Malaysia |
2004-11 | PHASE4 |
| NCT00238940 | COMPLETED | Renal Transplantation |
Novartis |
2003-02 | PHASE3 |
| NCT00006251 | COMPLETED | Acute Undifferentiated Leukemia; Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Childhood Burkitt Lymphoma; Childhood Diffuse Large Cell Lymphoma; Childhood Grade III Lymphomatoid Granulomatosis; Childhood Immunoblastic Large Cell Lymphoma; Childhood Myelodysplastic Syndromes; Childhood Nasal Type Extranodal NK/T-cell Lymphoma; Chronic Myelomonocytic Leukemia; Cutaneous B-cell Non-Hodgkin Lymphoma; de Novo Myelodysplastic Syndromes; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; Intraocular Lymphoma; Juvenile Myelomonocytic Leukemia; Mast Cell Leukemia; Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Myeloid/NK-cell Acute Leukemia; Nodal Marginal Zone B-cell Lymphoma; Noncutaneous Extranodal Lymphoma; Peripheral T-cell Lymphoma; Post-transplant Lymphoproliferative Disorder; Previously Treated Myelodysplastic Syndromes; Primary Systemic Amyloidosis; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Recurrent Childhood Anaplastic Large Cell Lymphoma; Recurrent Childhood Grade III Lymphomatoid Granulomatosis; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Small Noncleaved Cell Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Renal Cell Cancer; Recurrent Small Lymphocytic Lymphoma; Recurrent/Refractory Childhood Hodgkin Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Hairy Cell Leukemia; Refractory Multiple Myeloma; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Stage II Multiple Myeloma; Stage III Multiple Myeloma; T-cell Large Granular Lymphocyte Leukemia; Testicular Lymphoma; Waldenström Macroglobulinemia |
Fred Hutchinson Cancer Center |
2000-05 | PHASE1; PHASE2 |
| NCT00531063 | COMPLETED | Renal Transplantation |
Novartis Pharmaceuticals |
2001-11 | PHASE3 |
| NCT00531440 | COMPLETED | Renal Transplantation |
Novartis Pharmaceuticals |
2001-11 | PHASE3 |
| NCT00812123 | COMPLETED | Kidney Transplantation; Chronic Kidney Disease |
University Hospital, Basel, Switzerland |
2001-01 | PHASE4 |
| NCT00239031 | COMPLETED | Denovo Renal Transplantation |
Novartis |
2002-03 | PHASE3 |
| NCT00004482 | COMPLETED | Myocarditis; Giant Cell Myocarditis |
Mayo Clinic |
1999-12 | PHASE2 |
| NCT00238901 | COMPLETED | Liver Transplant |
Novartis |
2002-12 | PHASE3 |
| NCT00053014 | TERMINATED | Leukemia |
SWOG Cancer Research Network |
2003-04 | PHASE2 |
| NCT00405431 | COMPLETED | Glaucoma |
Wills Eye |
2004-03 | |
| NCT00005941 | COMPLETED | Cervical Cancer; Vaginal Cancer |
Fred Hutchinson Cancer Center |
1999-11 | PHASE2 |
| NCT01068054 | COMPLETED | Keratoconjunctivitis, Vernal |
Siriraj Hospital |
2003-06 | PHASE2; PHASE3 |
| NCT00644761 | COMPLETED | Hepatitis B |
Gilead Sciences |
2004-02 | PHASE2 |
| NCT00343226 | COMPLETED | Liver Transplantation |
Novartis |
2002-05 | PHASE4 |
| NCT00064701 | COMPLETED | Kidney Transplantation |
Astellas Pharma Inc |
2003-06 | PHASE3 |
| NCT00154232 | COMPLETED | Renal Transplantation |
Novartis Pharmaceuticals |
2004-06 | PHASE4 |
| NCT00003187 | COMPLETED | Leukemia; Lymphoma; Myelodysplastic Syndromes |
Virginia Commonwealth University |
1995-05 | PHASE2; PHASE3 |
| NCT02630563 | TERMINATED | Pediatric Liver Transplantation |
Hoffmann-La Roche |
2003-05 | PHASE2 |
| NCT00239057 | COMPLETED | Maintenance Renal Transplantation |
Novartis |
2002-05 | PHASE3 |
| NCT00239902 | COMPLETED | Renal Transplantation |
Novartis Pharmaceuticals |
2002-05 | PHASE2 |
| NCT00050648 | COMPLETED | Psoriasis |
Rockefeller University |
1997-10 | PHASE1; PHASE2 |
| NCT00005851 | COMPLETED | Recurrent Renal Cell Cancer; Stage IV Renal Cell Cancer |
Fred Hutchinson Cancer Center |
2000-02 | PHASE1; PHASE2 |
| NCT00003414 | COMPLETED | Graft Versus Host Disease; Lymphoma |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
1997-10 | PHASE3 |
| NCT00005866 | COMPLETED | Leukemia; Myelodysplastic Syndromes |
SWOG Cancer Research Network |
2000-02 | PHASE3 |
| NCT00653276 | COMPLETED | Cholesterol |
Organon and Co |
2003-11 | PHASE1 |
| NCT00001964 | COMPLETED | Severe Aplastic Anemia |
National Heart, Lung, and Blood Institute (NHLBI) |
2000-03-17 | PHASE2 |
| NCT00002547 | COMPLETED | Leukemia; Myelodysplastic Syndromes |
Barbara Ann Karmanos Cancer Institute |
1987-08 | PHASE2 |
| NCT00055653 | COMPLETED | Leukemia; Lymphoma; Myelodysplastic Syndromes; Myelodysplastic-Myeloproliferative Diseases |
Roswell Park Cancer Institute |
2003-01 | PHASE2 |
| NCT00317876 | COMPLETED | Fanconi Anemia |
Fred Hutchinson Cancer Center |
1998-06 | PHASE1 |
| NCT00016419 | COMPLETED | Leukemia; Myelodysplastic Syndromes |
SWOG Cancer Research Network |
2001-08 | PHASE2 |
| NCT00003056 | TERMINATED | Leukemia; Lymphoma; Graft Versus Host Disease |
Baxalta now part of Shire |
1997-04-01 | PHASE3 |
| NCT00002792 | COMPLETED | Chronic Myeloproliferative Disorders; Leukemia; Myelodysplastic/Myeloproliferative Diseases |
Fred Hutchinson Cancer Center |
1996-06 | PHASE2 |
| NCT00024128 | WITHDRAWN | Lymphoma |
AIDS Malignancy Consortium |
2001-08 | PHASE2 |
| NCT00041288 | TERMINATED | Leukemia; Lymphoma |
University of Texas Southwestern Medical Center |
2001-10 | PHASE2 |
| NCT00003954 | COMPLETED | Refractory Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma |
Fred Hutchinson Cancer Center |
1999-03 | PHASE1; PHASE2 |
| NCT00006054 | TERMINATED | Immunologic Deficiency Syndromes; Chediak-Higashi Syndrome; Common Variable Immunodeficiency; Graft Versus Host Disease; X-Linked Lymphoproliferative Syndrome; Familial Erythrophagocytic Lymphohistiocytosis; Hemophagocytic Lymphohistiocytosis; X-linked Agammaglobulinemia; Wiskott-Aldrich Syndrome; Chronic Granulomatous Disease; X-linked Hyper IgM Syndrome; Severe Combined Immunodeficiency; Leukocyte Adhesion Deficiency Syndrome; Virus-Associated Hemophagocytic Syndrome |
Fairview University Medical Center |
2000-03 | |
| NCT00048165 | COMPLETED | Heart Transplantation |
Hoffmann-La Roche |
1999-08 | PHASE4 |
| NCT00002759 | COMPLETED | Drug/Agent Toxicity by Tissue/Organ; Lymphoma; Neutropenia; Small Intestine Cancer; Unspecified Adult Solid Tumor, Protocol Specific |
National Cancer Institute (NCI) |
1996-06 | PHASE1 |
| NCT00002832 | COMPLETED | Leukemia; Myelodysplastic Syndromes |
M.D. Anderson Cancer Center |
1995-08 | PHASE1; PHASE2 |
| NCT00005988 | COMPLETED | Graft Versus Host Disease; Leukemia; Lymphoma; Myelodysplastic Syndromes; Myeloma |
Dana-Farber Cancer Institute |
2000-02 | PHASE1 |
| NCT00001626 | COMPLETED | Severe Aplastic Anemia (SAA) |
National Heart, Lung, and Blood Institute (NHLBI) |
1997-06-02 | PHASE2 |
| NCT00003625 | COMPLETED | Brain Tumors; Central Nervous System Tumors |
Children's Oncology Group |
1998-12 | PHASE1 |
| NCT00002961 | TERMINATED | Leukemia |
Children's Hospital of Philadelphia |
1995-10 | PHASE3 |
| NCT00006451 | WITHDRAWN | Graft Versus Host Disease; Leukemia; Lymphoma |
Masonic Cancer Center, University of Minnesota |
1996-04 | PHASE3 |
| NCT00002785 | COMPLETED | Leukemia |
Children's Oncology Group |
1996-07 | PHASE2 |
| NCT01177371 | COMPLETED | Accelerated Phase Chronic Myelogenous Leukemia; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Megakaryoblastic Leukemia (M7); Adult Acute Monoblastic Leukemia (M5a); Adult Acute Monocytic Leukemia (M5b); Adult Acute Myeloblastic Leukemia With Maturation (M2); Adult Acute Myeloblastic Leukemia Without Maturation (M1); Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With T(15;17)(q22;q12); Adult Acute Myeloid Leukemia With T(16;16)(p13;q22); Adult Acute Myeloid Leukemia With T(8;21)(q22;q22); Adult Acute Myelomonocytic Leukemia (M4); Adult Acute Promyelocytic Leukemia (M3); Adult Erythroleukemia (M6a); Adult Nasal Type Extranodal NK/T-cell Lymphoma; Adult Pure Erythroid Leukemia (M6b); Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Burkitt Lymphoma; Childhood Acute Erythroleukemia (M6); Childhood Acute Lymphoblastic Leukemia in Remission; Childhood Acute Megakaryocytic Leukemia (M7); Childhood Acute Monoblastic Leukemia (M5a); Childhood Acute Monocytic Leukemia (M5b); Childhood Acute Myeloblastic Leukemia With Maturation (M2); Childhood Acute Myeloblastic Leukemia Without Maturation (M1); Childhood Acute Myeloid Leukemia in Remission; Childhood Acute Myelomonocytic Leukemia (M4); Childhood Acute Promyelocytic Leukemia (M3); Childhood Chronic Myelogenous Leukemia; Childhood Myelodysplastic Syndromes; Chronic Phase Chronic Myelogenous Leukemia; Cutaneous B-cell Non-Hodgkin Lymphoma; De Novo Myelodysplastic Syndromes; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Peripheral T-Cell Lymphoma; Post-transplant Lymphoproliferative Disorder; Previously Treated Myelodysplastic Syndromes; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult Non-Hodgkin Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Refractory Multiple Myeloma; Relapsing Chronic Myelogenous Leukemia; Secondary Myelodysplastic Syndromes; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Testicular Lymphoma; Waldenstrom Macroglobulinemia |
Case Comprehensive Cancer Center |
1988-03 | PHASE2 |
| NCT00003661 | COMPLETED | Graft Versus Host Disease; Leukemia; Lymphoma; Myelodysplastic Syndromes; Neuroblastoma |
Roswell Park Cancer Institute |
1998-06 | PHASE2 |
| NCT00005935 | COMPLETED | Aplastic Anemia |
National Heart, Lung, and Blood Institute (NHLBI) |
2000-06 | PHASE2 |
| NCT00295425 | UNKNOWN | Psoriasis |
University Hospital Muenster |
2000-05 | PHASE2 |
| NCT00027547 | COMPLETED | Leukemia |
Fred Hutchinson Cancer Center |
2001-07 | PHASE1; PHASE2 |
| NCT00006055 | UNKNOWN | Purpura, Schoenlein-Henoch; Graft Versus Host Disease; Anemia, Hemolytic, Autoimmune; Rheumatoid Arthritis; Churg-Strauss Syndrome; Hypersensitivity Vasculitis; Wegener's Granulomatosis; Systemic Lupus Erythematosus; Giant Cell Arteritis; Pure Red Cell Aplasia; Juvenile Rheumatoid Arthritis; Polyarteritis Nodosa; Autoimmune Thrombocytopenic Purpura; Takayasu Arteritis |
Fairview University Medical Center |
2000-03 | |
| NCT00268515 | COMPLETED | Lung Diseases |
National Heart, Lung, and Blood Institute (NHLBI) |
1998-04 | PHASE2 |
| NCT00003920 | UNKNOWN | Breast Cancer |
University of California, Davis |
1996-04 | PHASE1 |
| NCT00389870 | COMPLETED | Colorectal Cancer |
University of Leeds |
2006-12 | PHASE3 |
| NCT00510913 | COMPLETED | Graft Rejection; Kidney Transplantation |
Astellas Pharma Inc |
1999-02 | PHASE4 |
| NCT00502073 | COMPLETED | Dry Eye Syndromes |
Sirion Therapeutics, Inc. |
PHASE3 | |
| NCT00257387 | COMPLETED | Kidney Transplant |
Wyeth is now a wholly owned subsidiary of Pfizer |
2004-06 | PHASE1; PHASE2 |
| NCT00002688 | UNKNOWN | Leukemia |
University Medical Center Groningen |
1995-02 | PHASE2 |
| NCT00436761 | UNKNOWN | Unspecified Childhood Solid Tumor, Protocol Specific |
Milton S. Hershey Medical Center |
2004-05 | PHASE1 |
| NCT01268995 | TERMINATED | New Onset Diabetes Mellitus After Renal Transplantation |
Medical University of Vienna |
2009-09 | PHASE2 |
| NCT00009776 | UNKNOWN | Lymphoma |
University of California, Davis |
2001-03 | PHASE1 |
| NCT00008307 | UNKNOWN | Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes |
Herbert Irving Comprehensive Cancer Center |
1998-04 | PHASE2 |
| NCT00008021 | UNKNOWN | Lymphoma |
University of California, Davis |
2001-02 | PHASE1 |
| NCT00824811 | WITHDRAWN | Epiphora |
M.D. Anderson Cancer Center |
2009-06 | PHASE2 |
| NCT00449059 | COMPLETED | Hypertension; Heart Transplantation |
University of Zurich |
2003-01 | PHASE4 |
| NCT00017654 | UNKNOWN | Graft Versus Host Disease; Aplastic Anemia |
Northwestern Memorial Hospital |
2001-04 | |
| NCT00001965 | COMPLETED | Cardiomyopathy, Hypertrophic; Heart Hypertrophy |
National Heart, Lung, and Blood Institute (NHLBI) |
1999-12 | PHASE2 |
| NCT00373815 | TERMINATED | Graft Versus Host Disease |
University Hospital Tuebingen |
2006-09 | PHASE1 |
| NCT00209859 | COMPLETED | Rheumatoid Arthritis |
Hvidovre University Hospital |
1998-10 | PHASE4 |
| NCT00378677 | UNKNOWN | Lung Transplantation; Bronchiolitis Obliterans |
University Medical Center Groningen |
2007-02 | EARLY_PHASE1 |
| NCT00729768 | WITHDRAWN | Kidney Transplantation |
Genentech, Inc. |
PHASE2; PHASE3 | |
| NCT00005854 | COMPLETED | Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes |
Fred Hutchinson Cancer Center |
1999-12 | PHASE2 |
| NCT00383396 | COMPLETED | Pterygia |
Innovative Medical |
PHASE4 | |
| NCT00020176 | COMPLETED | Breast Cancer |
National Cancer Institute (NCI) |
2000-06 | PHASE2 |
| NCT00001533 | COMPLETED | Anemia; Leukemia, T-Cell; Lymphocytosis; Neutropenia; Thrombocytopenia |
National Heart, Lung, and Blood Institute (NHLBI) |
1996-09 | PHASE1 |
| NCT00549289 | COMPLETED | Dry Eye Syndromes |
Sirion Therapeutics, Inc. |
PHASE3 | |
| NCT00080925 | COMPLETED | Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms |
National Institutes of Health Clinical Center (CC) |
2004-02 | PHASE1 |
| NCT00007787 | COMPLETED | Kidney Transplantation; Chronic Allograft Nephropathy |
National Institute of Allergy and Infectious Diseases (NIAID) |
2000-04 | |
| NCT00349583 | COMPLETED | Cataract; Dry Eye |
Innovative Medical |
PHASE4 | |
| NCT00443937 | COMPLETED | Renal Transplantation |
Charite University, Berlin, Germany |
2004-01 | PHASE4 |
| NCT00001839 | COMPLETED | Hematologic Diseases; Myelodysplastic Syndromes |
National Institutes of Health Clinical Center (CC) |
1998-12 | PHASE2 |
| NCT00335114 | COMPLETED | Contact Lens Wearers With Dry Eye Syndrome |
University of Alabama at Birmingham |
2005-11 | |
| NCT00110058 | COMPLETED | Leukemia |
Fred Hutchinson Cancer Center |
2005-02 | PHASE2 |
| NCT00139009 | COMPLETED | Renal Transplantation; Heart Transplantation |
University of Oslo School of Pharmacy |
2005-06 | PHASE4 |
| NCT00006233 | COMPLETED | Melanoma (Skin) |
Fred Hutchinson Cancer Center |
2000-01 | PHASE2 |
| NCT00428064 | COMPLETED | Renal Transplantation |
Wyeth is now a wholly owned subsidiary of Pfizer |
1998-05 | PHASE3 |
| NCT00143806 | COMPLETED | Psoriasis |
University of Medicine and Dentistry of New Jersey |
2003-10 | PHASE2 |
| NCT00054340 | COMPLETED | Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases |
Fred Hutchinson Cancer Center |
2002-10 | PHASE1; PHASE2 |
| NCT00066417 | TERMINATED | Chronic Myeloproliferative Disorders; Leukemia; Myelodysplastic/Myeloproliferative Diseases |
National Heart, Lung, and Blood Institute (NHLBI) |
PHASE2 | |
| NCT00009750 | UNKNOWN | Prostate Cancer |
University of California, Davis |
2001-03 | PHASE1 |
| NCT00166842 | UNKNOWN | Transplantation; Kidney Transplantation; Immunosuppression |
National Taiwan University Hospital |
2002-09 | PHASE4 |
| NCT00204191 | UNKNOWN | Kidney Transplantation |
Uniwersytet Mikolaja Kopernika w Toruniu |
2003-05 | PHASE4 |
| NCT00002456 | COMPLETED | Graft Versus Host Disease; Leukemia; Lymphoma |
Fred Hutchinson Cancer Center |
1986-05 | PHASE3 |
| NCT00031070 | COMPLETED | HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
PHASE2 | |
| NCT00248313 | COMPLETED | Kidney Disease |
Wyeth is now a wholly owned subsidiary of Pfizer |
2000-07 | PHASE3 |
| NCT00493194 | UNKNOWN | Kidney Failure, Chronic; Transplantation; Immunosuppression; Interstitial Fibrosis |
University Hospital, Antwerp |
2005-05 | PHASE4 |
| NCT00004323 | COMPLETED | Aplastic Anemia |
National Center for Research Resources (NCRR) |
1995-02 | PHASE2 |
| NCT00470665 | COMPLETED | Renal Allograft Recipients |
Wyeth is now a wholly owned subsidiary of Pfizer |
2002-08 | PHASE3 |
| NCT00009763 | UNKNOWN | Breast Cancer |
University of California, Davis |
2001-03 | PHASE1 |
| NCT00895739 | UNKNOWN | Nonmalignant Neoplasm |
Federico II University |
2006-06 | PHASE2 |
| NCT00024050 | COMPLETED | Leukemia; Myelodysplastic Syndromes |
Fred Hutchinson Cancer Center |
2001-02 | PHASE2 |
| NCT00000880 | COMPLETED | HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
PHASE2 | |
| NCT00081055 | WITHDRAWN | Graft Versus Host Disease; Leukemia; Myelodysplastic Syndromes |
Mesoblast International Sàrl |
PHASE2 | |
| NCT00006056 | UNKNOWN | Chediak-Higashi Syndrome; Graft Versus Host Disease; X-Linked Lymphoproliferative Syndrome; Familial Erythrophagocytic Lymphohistiocytosis; Hemophagocytic Lymphohistiocytosis; Virus-Associated Hemophagocytic Syndrome |
Fairview University Medical Center |
2000-03 | |
| NCT00166816 | UNKNOWN | Transplantation; Kidney Transplantation; Immunosuppression |
National Taiwan University Hospital |
2002-03 | PHASE4 |
(data from https://clinicaltrials.gov, updated on 2026-08-31)
Check the
Cyclosporine
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Compliance for Clinical Use
Mechanism and Biochemical Profile
Appendix RUO and cGMP Quality Standards
| Quality Dimension | RUO (Research Use Only) | cGMP (Current Good Manufacturing Practice) |
|---|---|---|
| Clinical Applicability | Prohibited in human clinical trials or medical diagnostics. | Mandatory for human clinical trials (Phase I–III) and therapies. |
| Regulatory Status | Non-regulated grade; exempt from drug manufacturing laws. | Legally enforced by health authorities (e.g., FDA, EMA, NMPA). |
| Facility Environment | Unclassified analytical or research laboratories. | Validated Cleanrooms (ISO Class 5–8) with continuous monitoring. |
| Quality Control | Basic purity and activity testing. | Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma). |
| Process Validation | Basic equipment calibration; no process validation required. | Full qualification (IQ/OQ/PQ) and complete batch records. |
| Quality Assurance | Vendor self-declared without required formal QMS. | Mandatory QA/QC unit, Change Control, CAPA, and vendor audits. |
| Regulatory Impact | High risk of IND rejection if used as a critical raw material. | Required for IND/NDA filings, supported by Drug Master Files (DMF). |
Footnotes
Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).
Jump to
Note: Technical data last updated: Sep 1, 2026.